Academic Pharmacy Now: 2014 Issue 3

Academic Pharmacy NOW

The News Magazine of the American Association of Colleges of Pharmacy

Volume 7 2014 Issue 3

Research Engines Drive Discovery At pharmacy schools across the country, faculty members are developing new treatments to fight some of the world’s deadliest diseases. 16

Also in this issue: 10 New IOM Pharmacy Fellow is eager to

make an impact on health policy makers.

American Association of Colleges of Pharmacy Discover · Learn · Care : Improve Health

Academic Pharmacy NOW

Volume 7 2014 Issue 3

Departments

Features 16 Breathe In to Snuff Out Ebola?

5 News Briefs 8 Academy in Action

• Exterminating Superbugs • New IOM Fellow Starts at the Top

By Maureen Thielemans

• A BRAIN’s Reaction

32 Members Working For You

• Straightening the Learning Curve

By Kyle R. Bagin

33 Faculty News

Researchers at The University of Texas at Austin are developing a promising weapon in the fight against Ebola.

20 Pharmacy Education 2014: Larger Than Life Expanded programming, enhanced learning opportunities, cuttingedge information— everything was bigger in Texas at the 2014 Annual Meeting.

23 A Double-Digit Achievement The AACP Walmart Scholars program celebrates a decade of mentorship.

Columns 3 Maine Message

By Lucinda L. Maine

7 Will on the Hill

By William G. Lang

2

ACADEMIC PHARMACY NOW 

2014 Issue 3

maine message Dear Colleagues: When this magazine was launched in 2008, AACP made a commitment to increase the visibility of the outstanding work of our members through a new communication vehicle. Many of you remember our earlier vehicle: the monthly AACP News in its maroon and white color signature. Photos were black and white! Perhaps more than any other feature, our newsletter was prized for the employment ads each issue carried. Monthly ads for faculty and administrative positions coming to you on paper and via snail mail—how 20th century!

Our current news magazine is designed to share so much more about the work of pharmacy faculty, students and the Association, and communicate it with a much wider audience. Will Lang, senior policy advisor, frequently shares features about the innovations occurring across the Academy with elected leaders and their staff members, as well as with other influential stakeholders in healthcare and higher education. Just in this issue alone, there is evidence of pharmacy faculty making important contributions to the epidemic of Ebola and the tragedy of resistant infections. Our members are truly smart and innovative, and contribute solutions to some of the world’s most vexing problems.

It is one of AACP’s highest priorities to serve as a conduit to get the information about your work to others.

That is the goal for an important new priority developing within the Association. This new initiative is the concept of “knowledge management” (KM), a construct that evolved in the consulting world where firms charge large fees to create solutions to clients’ problems. By gathering and organizing the intelligence across the entire company that often sits in isolated pockets of knowledge that are inaccessible to others, KM strategies allow organizations to advance more rapidly and progressively. AACP and its members possess incalculable information assets. This includes your education, practice and research innovation. Important knowledge resides in AACP reports, programs and communications.

AACP is fortunate to have been selected by the Sewell Fund to serve as a host organization for a one-year fellowship that embeds a librarian/information scientist in an organization that can use the skills of such an individual in a new and unique way. Dana Thimons, MLIS, AHIP, reference/academic support services librarian liaison to the College of Dental Medicine and College of Pharmacy at Nova Southeastern University, will begin her fellowship on January 5. She will focus on creating the practice of knowledge management at AACP and developing strategies to make all of our information assets much more visible and accessible to members, staff and others that can benefit from increased appreciation of our value. As we say in the 21st century, “watch this space for more information”!

The AACP Board and staff join me in wishing you the best holiday season. I hope your reflections on 2014 bring smiles to your faces and warmth to your heart.

Sincerely,

Lucinda L. Maine, Ph.D., R.Ph. CEO and Publisher

ACADEMIC PHARMACY NOW 

2014 Issue 3

3

Academic Pharmacy American Association of Colleges of Pharmacy 1727 King Street Alexandria, VA 22314 Phone: 703-739-2330 • Fax: 703-836-8982 www.aacp.org Founded in 1900, the American Association of Colleges of Pharmacy is the national organization representing the interests of pharmacy education. AACP comprises 133 accredited colleges and schools of pharmacy, including more than 6,400 faculty, approximately 62,500 students enrolled in professional programs and 5,100 individuals pursuing graduate study.

Academic pharmacy will transform the future of healthcare to create a world of healthy people.

AACP Mission

The mission of AACP is to lead and partner with our members in advancing pharmacy education, research, scholarship, practice and service to improve societal health.

We will accomplish this mission by:

• •

• •

•

•

• • •

Lucinda L. Maine Editorial Director

William G. Lang Editor

Maureen Thielemans

mthielemans@aacp.org

ACADEMIC PHARMACY NOW 

Kyle R. Bagin

kbagin@aacp.org Art Director

Tricia Gordon

tgordon@aacp.org Senior Advisor, Outreach and Communications

Stephanie Saunders Fouch sfouch@aacp.org

Providing forums for faculty development and networking.

Disseminating cutting-edge pedagogy related to professional and graduate education.

Fostering environments and stimulating the development of resources that support the research and scholarship of faculty.

Creating leadership and advocacy skills development opportunities for members and students.

Fostering development of innovative professional and graduate education programs, assessment, resources and strategies.

Facilitating members’ development, evaluation and dissemination of new practice models through collaboration with other healthcare organizations and practitioners.

Facilitating development of products, programs and services for members that create efficiencies and effectiveness, and enhance value.

Ensuring the appropriate infrastructure and resources are in place to advance our mission.

Providing advocacy for academic pharmacy.

Supporting faculty and graduates dedicated to and equipped for life-long learning, utilizing models of continuing professional development.

4

CEO & Publisher

Editorial Assistant

AACP Vision

•

NOW

2014 Issue 3

Letters to the Editor We welcome your comments. Please submit all letters to the editor to communications@aacp.org.

About Academic Pharmacy Now Academic Pharmacy Now highlights the work of AACP member pharmacy schools and faculty. The magazine is published as a membership service.

Subscriptions To subscribe, visit http://www.aacp.org/news/shopaacp/ Pages/publications.aspx.

Change of Address For address changes, contact Terry J. Ryan, Associate Director of Membership Development, at tryan@aacp.org.

Advertising For advertising rates, please visit http://www.aacp.org/ news/academicpharmnow/pages/advertisingwithaacp.aspx. ©2014 by the American Association of Colleges of Pharmacy.

All rights reserved. Content may not be reprinted without prior written permission.

News Briefs Study Examines MTM Benefits for HomeHealth Patients

University of Michigan Pharmacists Find Not All HIV Viruses Created Equal

Low-risk Medicare patients entering home healthcare HIV-infected people carry many different HIV viruses and who received medication therapy management (MTM) by all have distinct personalities—some much more vengeful phone were three times less likely to be hospitalized with- and infectious than others. Yet, despite the breadth of inin the next two months, while those at greater risk saw no fectivity, roughly 76 percent of HIV infections arise from benefit, according to a study led by Purdue University. The a single virus. Now, scientists believe they can identify the study helped determine which patients benefit most from culprit with very specific measurements of the quantities medication therapy management by phone and a way to of a key protein in the HIV virus. The study is thought to identify them through a standardized risk score, said Dr. be the first in which researchers were able to capture HIV Alan J. Zillich, associate professor of pharmacy practice at the single-particle level and measure with molecular at Purdue. resolutions, said principal investigator Dr. Wei Cheng, associate professor at the University of Michigan College of During MTM a pharmacist evaluates the medications pre- Pharmacy. Cheng’s group found that the HIV virus parscribed and how a patient is feeling to identify and resolve ticles have different quantities of a key protein that enables issues, including untreated conditions, drug interactions, virulence, and the protein-rich virus particles were more adverse drug reactions, inappropriate drugs or doses, and infectious than the others. whether a patient is taking the medications as prescribed.

Zillich led a team of researchers who collaborated with the The ability to measure molecular differences means that home healthcare organization Amedisys Inc., and phar- drugs could be developed to target the molecular features macists from Curant Health, who provided the medication present in the more virulent strains, Cheng said. His labotherapy management intervention. A paper detailing the ratory developed and used a new optical technique to mearesearch was published in the journal Health Services Re- sure the HIV viral particles. The team improved upon an already existing tool called optical tweezers, which uses search and is available online. photons, or light, to manipulate tiny molecular motors The most common types of medication-related errors are or nanostructures. This immobilizes the structure and identified soon after transitions of care take place and the enables contact-free study that doesn’t disturb or distort first days are the most critical, Zillich said. “The transi- the structure. The technique, which allows scientists to tion to home-based care—as with any type of transition determine a particle’s virulence, also has the potential for in care—is a vulnerable time for patients. It involves a sorting of viruses and application in other deadly viruses. switch in healthcare providers and sometimes a delay in Cheng said he hopes to learn which strains of HIV conthe handoff of medical records. The patients likely have tain the most dangerous viral particles most likely to infect had significant changes or additions to their medications, healthy cells. and sometimes medication-related problems are just starting to appear.”

The results showed no overall significant difference in the 60-day probability of hospitalization for those who received medication management therapy by phone versus those who did not. However, when the patients were evaluated based on their risk profiles, those in the lowest-risk group who received the service were three times more likely to remain out of the hospital 60 days after entering into home healthcare. It is unclear why one group benefited from the intervention more than the others, but Zillich said face-toface medication therapy management might be more helpful to higher-risk patients.

University of the Pacific Students Involved in Groundbreaking Cancer Research

The National Institutes of Health awarded Dr. William Chan, a professor at the University of the Pacific Thomas J. Long School of Pharmacy and Health Sciences, a threeyear, $367,000 grant to further his research on the aryl hydrocarbon receptor (AhR), a human cellular component, which reacts to environmental pollutants and plays a role in the body’s response to cancer and autoimmune diseases.

Chan’s laboratory has 10 pharmacy, undergraduate and graduate students each year actively involved in conducting experiments. Student participation in biomedical research is one of the goals for this type of NIH grant.

ACADEMIC PHARMACY NOW 

2014 Issue 3

5

news briefs “The NIH places a high priority on students taking part in biomedical research so that they can get excited about it and possibly pursue this as a career,” said Chan.

The AhR interacts with molecules such as dioxins, which get into the food chain from industrial pollution and auto exhaust. “Dioxins are known to cause cancer in rodents,” said Chan, “and they are very resistant to degradation in our bodies. They hang around for a long time.” Chan said that his research is examining how the AhR levels—found to be higher in individuals with some cancers—may be lowered on a cellular level. “If we can understand how we can lower the receptor amounts in these cancer cells to stop the cancer growth, then we could make a drug to control this process.” According to the NIH, more than 30 million Americans are afflicted with cancer or autoimmune diseases.

UCSF Receives Grant to Develop Antibiotics That Overcome Drug-Resistant Bacteria Dr. James A. Wells, chair of the University of California, San Francisco School of Pharmacy’s Department of Pharmaceutical Chemistry, has received a two-year, $220,814 grant from the National Institute of Allergy and Infectious Diseases to develop a promising new class of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE).

Thiopeptides, isolated from certain soil and marine bacteria, are promising because they intervene at a different ribosomal site compared with current classes of antibacterials.

Wells and his graduate student Hai Tran, in collaboration with Department of Pharmaceutical Chemistry colleague Dr. Susan Miller, and Dr. Christopher Walsh, at Harvard Medical School, will be studying the thiopeptide thiocillin.

They have devised new methods to rapidly alter the genes that express potential drugs in a common Bacillus cereus bacterium, and then screen the diversified output against the resistant microbes. Typically, modifications of natural products would require a team of medicinal chemists to make even a dozen peptide variants (analogs). The system they have devised allows the generation of hundreds or thousands of derivative natural products, in a renewable fashion, to target further emerging resistance and to screen against other bacterial and human targets.

6

ACADEMIC PHARMACY NOW 

2014 Issue 3

Novel Approach to Drug Delivery for Lung Transplant Patients Only about half of lung transplant recipients survive five years after the procedure, according to the National Institutes of Health. A transplant patient must take immunosuppressant medications for the rest of his or her life so that the body does not reject the new organ, which leaves him or her susceptible to myriad deadly infections and diseases.

Dr. Robert O. (Bill) Williams, chair of the pharmaceutics division at The University of Texas at Austin College of Pharmacy, is working on a new method to administer the immunosuppressant drug for transplant patients so that it goes straight to the lungs without traveling through—and damaging—the rest of the body.

Currently, patients take the drug as a capsule or tablet. Williams and his research partner, Dr. Jay Peters, a physician at the UT Health Science Center in San Antonio and an adjunct professor in the College of Pharmacy, developed new technologies that convert the drug particles into aggregates of nanoparticles so the medicine can be inhaled directly into the lungs by either a nebulizer or dry-powder inhaler. “Our theory is that if we get it right to the site where the immune suppression is needed, then we would have fewer systemic side effects,” Williams said.

The drug in this new delivery form tested successfully in healthy human volunteers. The next step for Williams and Peters is licensing out to a pharmaceutical company for clinical trials and submitting to the regulatory process. Lung transplant patients could be using the medicine, which could drastically improve their life expectancy, within four years.

Online Only: Academic Pharmacy Now’s In Memoriam Section The In Memoriam section regularly featured here will now be published exclusively online at www.aacp.org.

will on the hill

Innovation At Risk

Overcoming political barriers to funding means proving the value of innovation.

By William G. Lang In this edition, as in almost every edition of Academic Pharmacy Now, innovation is a key story ingredient. This publication showcases the groundbreaking research undertaken by our faculty that improves the quality of education and healthcare. Faculty News provides a ready example that pharmacy faculty, supported by a wide-range of public and private grants, are on the cutting-edge of discovery and innovation. This evidence is regularly shared with policy makers as proof that the funding of federal public health agencies and the grants they provide have real value to the American public. Yet, this value and the importance of innovation are continuously undermined in the name of improved government efficiency.

On A Mission One example that comes to mind is the assault on innovation affecting the Agency for Healthcare Research and Quality (AHRQ) and National Science Foundation (NSF).

AHRQ suffers from an identity crisis that is even difficult for advocates to demystify. When members of Congress seek ingenious (or disingenuous) approaches for reducing federal spending, AHRQ is frequently an easy target. You would think this agency had an intrinsic value in evidence-based policy development when you read its mission statement: “AHRQ’s mission is to produce evidence to make health care safer, higher quality, more accessible, equitable, and affordable, and to work with the U.S. Department of Health and Human Services (HHS) and other partners to make sure that the evidence is understood and used.” The target on AHRQ’s back is not just what it funds, but the way it gets its funding. AHRQ is not funded through direct appropriations like most other federal agencies. AHRQ receives its funding through an “evaluation tap.” Read the mission statement again. AHRQ partners with HHS to make sure evidence is understood and used. To help that partnership, HHS agencies, including the National Institutes of Health and the Centers for Disease Control and Prevention, provide support to AHRQ with its funding through an assessment, the evaluation tap.

All Tapped Out The evaluation tap is less understood than the mission of AHRQ. Members of Congress are considering eliminating the evaluation tap as a mechanism for increasing funding to the federal agencies subject to the tap. This is a red her-

ring! The evaluation tap is calculated as an annual cost in the agency budget. The tap does not really reduce the agency funding. They recognize it in their budget and benefit from the partnership with AHRQ. In short, no tap, no AHRQ— and no need for innovation, since no federal agency would be responsible for coordinating the effective use of evidence.

The other issue is the competitive grant funds that NSF makes available for behavioral, social and economic sciences.

The committee agreed to a reduction in more than $40 million for this research during discussions authorizing FY15 appropriations for the NSF. On that very same day, George Will, a nationally-syndicated columnist, wrote a piece describing the need for greater research in behavioral and social sciences. At a time when the evidence shows behavioral health is important to improving the lives of millions of vulnerable Americans (including our veterans returning from wars with dramatic physical challenges), why would we want to decrease funding for innovation in this area of health and wellness? At a time when we are attempting to change our healthcare delivery system to one that expects more patient engagement, how do we find the innovative ways to make that a reality? Interestingly, the House Subcommittee on Commerce, Justice and Science included language in their report requiring NSF to make sure the research it supports is in the national interest. Is this another example of fiscal restraint serving as a red herring for political ideology?

These assaults require our Academy to be honest about the value of its research and interest in innovation that improves the public health and well being. How would you describe your innovation to a member of Congress?

William G. Lang is Senior Policy Advisor at AACP; wlang@aacp.org.

UPDATE: The FY15 funding legislation passed by the U.S. Congress in December provided AHRQ with a direct appropriation. This means that AHRQ will receive its funding without depending on “taps” from other HHS agencies. While this is a significant win for the advocates of AHRQ, report language in the FY15 legislation clearly reflects a continued lack of understanding of the research continuum and the benefit to society at steps along this continuum. This will require continued advocacy by AACP and its advocacy partners.

ACADEMIC PHARMACY NOW 

2014 Issue 3

7

academy in action

Exterminating Superbugs Scientists at the University at Buffalo, The State University of New York are turning to an old class of antibiotics to fight new superbugs resistant to modern medicine.

By Sara Saldi, University at Buffalo A $4.4 million grant from the National Institutes of Health Tsuji and his team will then translate this knowledge back will allow University at Buffalo researchers to develop new to the bedside by proposing new, optimal regimens that dosing regimens for polymyxin antibiotics. Developed can be utilized by patients. Gram-negative bacteria, which more than 50 years ago, polymyxins were not subject to do not retain a gram-staining process used in the laboramodern antibiotic drug development standards and have tory to differentiate bacteria, are causing a global health proven to be toxic to both the kidneys and nervous system. crisis, Tsuji explains.

But they’re also effective against superbugs such as Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsi- “This is a massive public health problem because the ella pneumoniae and other gram-negative bacteria that are emergence of these new highly resistant strains has been resistant to all current antibiotics and which can cause a coupled with a dwindling pipeline of development and apvariety of diseases, ranging from pneumonia and other re- proval for new drugs,” he says. He notes that polymyxins spiratory infections, to serious blood or wound infections. remain a viable option, but there is mounting evidence that even resistance to polymyxins is also increasing, and no The grant is the largest NIH grant in the history of the UB new antibiotics will be available for these superbugs for School of Pharmacy and Pharmaceutical Sciences. The re- many years to come. search, led by Dr. Brian Tsuji, associate professor and director of clinical research in the Department of Pharmacy Prac- Because of this, clinicians are often left with little or no tice, aims to evaluate novel dosing regimens for polymyxin option but to use polymyxins (polymyxin B and colistin, combinations, in order to maximize antibacterial activity i.e. polymyxin E). Resistance to polymyxins is increasing because plasma concentrations at recommended daily and minimize the emergence of resistance and toxicity. doses are not effective in reducing infection in critically

Credit: @2014 University at Buffalo

8

ACADEMIC PHARMACY NOW 

2014 Issue 3

academy in action

Credit: @2014 University at Buffalo

Dr. Brian Tsuji (above) will lead an international research team on the largest NIH grant in the history of the UB School of Pharmacy and Pharmaceutical Sciences.

ill patients. Increasing the dose is not an option because they may cause kidney toxicity at higher doses. “Therefore,” Tsuji says, “we needed to think innovatively and differently about how to attack this problem.”

Researchers will use an innovative Hollow Fiber Model System in Tsuji’s lab to mimic the concentrations of antibiotics in patients against bacteria from critically ill patients.

“We want to mimic conditions seen in real patients who are infected with these deadly strains by using model systems that mirror exact drug concentrations in the body,” he says.

“In the lab, we can study these combination regimens very intensely over the same time frame that we would treat a patient with bacterial pneumonia (14 days) to understand the fundamental basis for drug resistance.

“This will allow us to address the public health disaster of antimicrobial resistance and to fight these deadly infections in severely ill patients where no traditional treatments exist.”

Tsuji has put together a team of world-renowned experts in polymyxin pharmacology, genomics, animal models and pharmacokinetics/pharmacodynamics (PK/PD). The

international, interdisciplinary team is also co-led by Dr. Jian Li, PI, and includes Dr. Roger Nation and Dr. John Boyce, all from Monash University, Melbourne, Australia; and Dr. Thomas Walsh and Dr. Vidmantas Petraitis from Weill Cornell Medical College, New York City.

The research team also includes experts in PK/PD, including Dr. Alan Forrest and Dr. Gauri Rao from the UB Department of Pharmacy Practice, and former UB postdocs Dr. Juergen Bulitta and Dr. Cornelia Landersdorfer, both now of Monash University.

The team of Forrest, Bulitta, Landersdorfer and Rao, which will develop mathematical models to perform computer simulations that propose optimal doses of polymyxin combinations for patients in the study, was critical for the success of the grant, Tsuji says. Technicians and students in his lab, including Patricia Holden and Neang Ly, generated key preliminary data to make the grant possible.

Sara Saldi is News Content Manager, Dental Medicine, Libraries, Nursing, Pharmacy, RIA

ACADEMIC PHARMACY NOW 

2014 Issue 3

9

academy in action

New IOM Fellow Starts at the Top A University of Florida pharmacy professor aims high to influence health policy makers.

By Maureen Thielemans Dr. Steven M. Smith, clinical assistant professor in phar- elected IOM member macotherapy and translational research and community pharmacy Dean Julie A. health and family medicine at the University of Florida Johnson and UF Health Colleges of Pharmacy and Medicine, is thinking outside President David S. Guzthe bubble when it comes to healthcare policy. He believes ick, he was ready to that in order to make a significant impact on health policy, throw his hat in the ring. researchers and clinicians must make their work accessible to those outside the academic bubble. In other words, Starting At the Top “How do we reach the people who aren’t trained the same “As clinicians and researchers, we don’t alway we are?” he asked. ways have a good sense One way Smith plans to accomplish this is through the of how our work can be Institute of Medicine (IOM) Anniversary Pharmacy Fel- translated to health pollowship. He joins Dr. Jennifer Christian, senior director icy decision makers, and I think that’s particularly true with of clinical effectiveness & safety at GlaxoSmithKline, as pharmacy,” said Smith. “There’s a small group of people adone of two fellows in the program that enables early career vocating on behalf of pharmacy, but it’s not nearly the same health policy or health science scholars to participate in machine that medicine and nursing have.” the work of the IOM and to further their careers as future To make a big impact on health policy makers, Smith knew leaders in the field. the IOM was the place to start. “The Institute of Medicine In Part One of a series featuring the new fellows, Smith is the nexus of accomplished researchers, clinicians and talks about his plans to make an impact on the big stage other experts,” he said. “When you combine their experand ultimately move the profession of pharmacy forward. tise and the knowledge of IOM staff, you see why policy makers, like congressmen, really listen.”

First-hand Account

Smith’s career path began at the Veterans Administration where he completed a PGY1 residency after receiving his Pharm.D. in 2007 from the University of Florida. Upon returning to UF for a postdoctoral fellowship in family medicine research, he was invited to be part of the APPCI (Advanced Postgraduate Program in Clinical Investigation) program and concurrently completed his M.P.H. degree.

At the University of Colorado, Smith joined the faculty as assistant professor and met inaugural IOM Fellow Dr. Samuel G. Johnson, who introduced him to the roles and responsibilities of the fellowship. “I asked Sam many questions—‘What does it entail? What have you learned? Who did you meet?’ The experiences he described sounded fascinating,” Smith said. His interest in the two-year program grew as he and Johnson worked together, and thanks to support from IOM member colleagues at UF, including newly

10

ACADEMIC PHARMACY NOW 

2014 Issue 3

In October, Smith was announced as one of two pharmacy fellows at the IOM’s annual meeting in Washington, D.C. He and Christian networked with new fellows, met other IOM members and engaged with prominent players in healthcare. A week later, they returned to the nation’s capital for a hands-on orientation. Fellows select a board of the IOM and participate in the work of an appropriate expert study committee or roundtable, helping contribute to its report or other products. Smith and Christian wanted to absorb as much as they could before selecting a project.

Building Consensus Early next year, Smith will begin working on projects at the IOM. Fellows have the option of aligning themselves with any board, roundtable or forum and are encouraged to consider areas outside of their primary research or policy expertise.

academy in action

A Pharmacy First

“This fellowship allows me to learn about issues from an incredibly wide range of views.”

—Dr. Steven M. Smith

One primary activity of an IOM board is completing a consensus study on a particular topic. The board brings in a group of experts, some of which are IOM members while others are not, to develop reports that provide recommendations reached by group consensus. To Err Is Human and Crossing the Quality Chasm are two examples of the IOM’s landmark consensus reports.

Smith hopes to work on a consensus report in its early stages. “I want to be involved in the ‘gold standard’ IOM reports,” he said. “And really see what a consensus study entails from cradle to grave.” This includes participating in group discussions, working with IOM staff to edit drafts, and being involved in the report’s publication and dissemination.

A New Journey As Smith’s work progresses over the next two years, he says building upon Sam Johnson’s accomplishments will be at the forefront of his mind. He also wants to take advantage of the networking opportunities and exposure to some of the leading minds who are tackling important healthcare issues—experts that are outside the bubble.

The University of Florida (UF) was well represented at the IOM Annual Meeting in October. Dr. Julie A. Johnson, dean and distinguished professor of pharmacy and medicine at the UF College of Pharmacy, was announced as one of 70 new members. The appointment is the first ever for a pharmacy faculty member.

To date, only eight faculty members at UF, all men, have held IOM membership, starting with the university’s seventh president, Dr. Robert Marston, in 1973.

“Dr. Johnson’s election to the IOM by its membership reflects her fundamental contributions to our understanding of how drugs affect people differently depending on their genetics,” said David S. Guzick, senior vice president for health affairs at UF and president of UF Health, and 2008 IOM member. “[This] has led to clinical application in the areas of antihypertensive drugs and drugs such as warfarin that are used to prevent clot formation. Because of her extensive knowledge and insights about pharmacogenomics and personalized medicine, she will be of great service to the IOM and the nation.”

“This fellowship allows me to learn about issues from an incredibly wide range of views,” he said. “Hearing all those diverse voices will really improve my ability to think about my messaging.”

Smith also stresses the importance of financially supporting opportunities such as the IOM fellowship. “We have to find ways to keep it going, and engage early-career pharmacy professionals in health policy making at all levels.”

Maureen Thielemans is Associate Director of Communications at AACP and editor of Academic Pharmacy Now; mthielemans@aacp.org.

ACADEMIC PHARMACY NOW 

2014 Issue 3

11

academy in action

A BRAIN’s Reaction A collaborative research effort at UNC Chapel Hill could lead to more targeted treatments for neuropsychiatric disorders.

Edited and compiled by Jane E. Rooney The quest to find new treatments and cures for brain disorders and diseases, including depression and dementia, just got a significant boost. A group of University of North Carolina at Chapel Hill (UNC) researchers received a $2.85 million, three-year grant to improve a brain research tool through a first round of funding from the National Institutes of Health as part of the White House BRAIN Initiative. The researchers will use the grant funding to develop the next generation of a tool called DREADDs, which stands for Designer Receptors Exclusively Activated by Designer Drugs. Using the DREADDs tool, researchers can study the mechanisms of commonly targeted brain receptors and individual neurons, as well as the specific effects of certain drugs.

“This BRAIN Initiative grant will be used to improve DREADDs with the ultimate goal that we can develop precisely targeted treatments for a host of neuropsychiatric disorders, such as autism, addiction, depression, anxiety, schizophrenia, seizure disorders, Alzheimer’s and Parkinson’s disease,” said Dr. Bryan Roth, a professor in the UNC at Chapel Hill Eshelman School of Pharmacy, as well as a professor of protein therapeutics and translational proteomics at the UNC School of Medicine. Roth, who developed the DREADD technology, is a member of the UNC Neuroscience Center and the UNC Lineberger Comprehensive Cancer Center.

According to Roth, the DREADDs tool allows for the remote control of cellular signaling. “Essentially, it involved G-protein coupled receptors, which have been engineered to be activated by a drug-like compound that is inert,” he explained. “We can then express them in essentially any cell type in the body and modulate signaling for therapeutic or research purposes.”

Roth said the research “has allowed us to identify cells and signaling pathways essential for a large number of potential therapeutic applications.” He added that it would not

12

ACADEMIC PHARMACY NOW 

2014 Issue 3

have been possible to accomplish these breakthroughs without the collaboration among researchers.

The project’s other two principal investigators are Dr. Thomas Kash, assistant professor of pharmacology in the UNC School of Medicine; and Dr. Jian Jin, associate professor and director of the Medicinal Chemistry Center for Integrative Chemical Biology and Drug Discovery in the UNC Eshelman School of Pharmacy. With the grant, Roth’s lab will use cells in culture to create novel DREADD technologies while Kash’s lab will evaluate the effectiveness of the new and improved methods in animal models. Jin will develop new compounds that will allow researchers to more precisely activate the G-coupled receptors of individual cell types in the particular brain regions.

Jane E. Rooney is a freelance writer based in Oakton, Virginia.

Have you been taking advantage of AACP’s online learning opportunities?

Webinar registration is free for AACP members.

Visit www.aacp.org for more information.

academy in action

Membership Renewal Is Open AACP Membership: A rich collection of programming, resources and professional development opportunities TMP PRODUCTION

1 7/14/2014 In addition to the many CH059965B ongoing member benefits—Sections and SIGs, AJPE,

Academic Pharmacy Now, E-lert Newsletters, the Annual Meeting and more— TMEADOW

7 x 4.5

WALGR0002

AACP is expanding its portfolio of member offerings. New n/a services include:

rd

expanded Webinar programming, new Learning Technology—Mimycx, the enhanced Member Profile, and more networks for collaboration!

Renew Your Membership Today: http://www.aacp.org/about/join

at the corner of

UNIQUE TALENTS

A COMMON

GOAL

Our expanding offerings like Take Care Health and Walgreens Health Services - mean that everyone from nurses and occupational therapists to dietitians, physical therapists and pharmacists can provide a level of care like never before.

To apply, visit www.walgreens.jobs Walgreens is an Equal Opportunity Employer and welcomes individuals of diverse talent and backgrounds. Walgreens promotes and supports a smoke-free and drug-free workplace.

ACADEMIC PHARMACY NOW 

2014 Issue 3

13

NUMEROUS APPLICANT POOLS, ONE ADMISSIONS SOFTWARE Graduate programs can now take advantage of all the benefits Liaison offers through their Centralized Application Services. From giving your admissions staff more tools to recruit and communicate with applicants, to analyzing application trends, to leveraging mobile capabilities – PharmDirect simplifies the application process and gives your institution a competitive edge.

www.liaison-intl.com

feature story

16

ACADEMIC PHARMACY NOW 

2014 Issue 3

feature story

Breathe In to Snuff Out Ebola?

Researchers at The University of Texas at Austin College of Pharmacy may have a treatment for Ebola in the form of a breathable vaccine.

Edited and compiled by Jane E. Rooney

ACADEMIC PHARMACY NOW 

2014 Issue 3

17

feature story The current Ebola outbreak in Western Africa, which had a fatality rate as high as 70 percent in mid-October, is considered an international public health emergency by World Health Organization officials. The Ebola virus is spread among the human population via direct contact with blood or bodily fluids from an infected individual. No licensed vaccines or treatments currently exist, so the race is on to find a way to stop the epidemic as quickly as possible.

Researchers at The University of Texas at Austin College of Pharmacy are developing a potentially breathable, respiratory vaccine that has been shown to provide long-term protection for non-human primates against the deadly virus. Results from a recent pre-clinical study represent the only proof to date that a single dose of a non-injectable vaccine platform for Ebola is long lasting, which could have significant global implications in controlling future outbreaks.

A respiratory vaccine could surmount the logistical obstacles of storing, transporting and administering injectable vaccines in parts of Africa most afflicted by the virus.

Cost and Safety Advantages College of Pharmacy Professor of Pharmaceutics Dr. Maria A. Croyle, graduate student Kristina Jonsson-Schmunk and colleagues spent more than seven years developing a respiratory formulation that improved survival of immunized non-human primates from 67 percent to 100 percent after challenge with 1,000 plaque-forming units of Ebola Zaire 150 days after immunization. This improvement is statistically significant because only 50 percent of the primates given the vaccine by the standard method of intramuscular injection survived challenge.

“The main advantage of our vaccine platform over the others in clinical testing is the longlasting protection after a single inhaled dose,” said Croyle. “This is important since the longevity of other vaccines for Ebola that are currently being [tested] is not fully evaluated.

Moreover, this immunization method is more attractive than an injectable vaccine given the costs associated with syringe distribution and needle safety and disposal.”

Croyle and Jonsson-Schmunk, who co-authored a research paper with Dr. Gary Kobinger and his team at the National Microbiology Laboratory in Winnipeg, presented their work in San Diego in November at the 2014 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world’s largest pharmaceutical sciences meeting. A grant from the National Institutes of Health supported their work.

“There is a desperate need for a vaccine that not only prevents the continued transmission from person to person, but also aids in controlling future incidences,” said Jonsson-Schmunk. A respiratory vaccine also presents advantages to the healthcare professionals who come into contact with patients.

“Use of a needle-free vaccine would mean several things for healthcare workers,” said Croyle.

“First, it would minimize the chance that they contract Ebola or HIV while administering the vaccine since there would be no needles with residual blood on them involved. Second, the respiratory platform is very amenable to self-administration, meaning that more of their time could be spent tending to patients who are seriously ill with the Ebola virus.”

Next Steps The next stage of research for Croyle’s team is a phase I clinical trial that tests the effectiveness of their vaccine in human subjects. They will also further explore preliminary data they

18

ACADEMIC PHARMACY NOW 

2014 Issue 3

feature story Dr. Maria A. Croyle, professor of pharmaceutics at The University of Texas at Austin College of Pharmacy, has spent more than seven years developing a respiratory vaccine for Ebola.

A needle-free solution would limit residual blood and therefore, help curb transmission.

have collected for administering the vaccine as a thin film under the tongue in non-human primates.

As to whether clinical trials can be expedited given the urgency of this health crisis, Croyle said, “I think it is important that phase I safety testing be conducted carefully and on a fairly large scale since it is paramount that side effects that may arise from these treatments be minimized, and a significant amount of information about the response to the treatments be collected prior to distribution of these agents on a larger scale.”

She added that there are two target populations, and their receptiveness to the vaccine varies widely. “There are the healthcare workers/first responders who could greatly benefit from a vaccine and, because of their training, understand the risks and benefits of experimental therapeutics,” she noted. “The second population, those in the regions where the outbreak is still strong, is a bit more fragile. The understanding of experimental treatments is limited and trust of healthcare and government officials is weak. Pushing candidates through clinical testing in these areas is a slippery slope as the hopes and expectations for a cure are high.

Providing something that does not consistently meet those expectations or that causes unwanted effects will compromise trust and communication lines that have taken much effort to establish, and could potentially make a difficult situation much worse.”

Jane E. Rooney is a freelance writer based in Oakton, Virginia.

ACADEMIC PHARMACY NOW 

2014 Issue 3

19

feature story

2014:

Larger Than Life Expert speakers, informative exhibitors, innovative resources and practical applications made learning the big story at this year’s Annual Meeting.

By Maureen Thielemans and Kyle R. Bagin

The 2014 AACP Annual Meeting was host to countless opportunities for dynamic discussion. Attendees visiting the Exhibit Hall had a chance to explore hundreds of research and education topics with experts and award winners from around the country.

20

ACADEMIC PHARMACY NOW 

2014 Issue 3

@peggyinlex “Altruism is a way of life @UofOklahoma.” Congratulations, Oklahoma, on the Weaver Transformative Community Service Award. #PharmEd14

feature story

AACP President Peggy Piascik, Ph.D., presents the Lawrence C. Weaver Transformative Community Service Award to The University of Oklahoma College of Pharmacy. Recipients are chosen for their major institutional commitment to addressing unmet community needs.

Expanded programming, enhanced learning opportunities, cutting-edge information—everything was bigger and better in Texas for Pharmacy Education 2014! More than 2,000 pharmacy administrators, faculty and staff met July 26–30 in the Lone Star State to embark on four days of professional growth and development. Following are just some of the highlights from the premier academic pharmacy event of the year.

ACADEMIC PHARMACY NOW 

2014 Issue 3

21

feature story A Double-Digit Achievement AACP Walmart Scholars agree: Program’s 10th year exceeded expectations.

By Lauren A. Clouse, Pharm.D. Candidate, UNC Eshelman School of Pharmacy Class of 2015

A Little Something Extra There was something for everyone at this year’s Annual Meeting pre-sessions. Admissions officers, business development professionals, and promising researchers were just some of the attendees who took advantage of programming before the big show.

At the Teachers Seminar, Repair, Re-inflate, Re-align, Replace: What do your teaching tires need?, educators from around the country were eager to assess their current teaching capabilities. They were challenged to forget the traditional way of doing things and to develop new and innovative teaching techniques. Dr. Patrick T. Jackson, associate dean for undergraduate education and professor of international relations in the School of International Service at American University, described the three kinds of knowing to set the stage for the day: knowing what, know-how and knowing from within. He used driving as a metaphor but cautioned that driving does not equal teaching. Why not? Because you drive defensively to prevent accidents, but if you teach defensively, no one learns anything. Class format, technologies and assessment are elements to consider with the three types of knowing, he said.

The AACP Walmart Scholars Program celebrated its 10th successful year at the 2014 AACP Annual Meeting, July 26–30, in Grapevine, Texas.

Eighty five student and faculty mentor pairs attended innovative sessions, networked with peers and returned to their institutions with enhanced leadership and professional skills to help them prepare for a career in academia.

“The Teacher’s seminar at Pharmacy Education 2014 was well worth it,” one attendee tweeted. “I’m feeling motivated and got great ideas from fellow educators!”

The Scholars, comprised of graduate students, professional students, residents, and fellows, along with their faculty mentor, received a $1,000 scholarship to attend both the Annual Meeting and Teachers Seminar. Walmart’s commitment to faculty recruitment was recognized with the prestigious AACP Distinguished Service Award. “At Walmart and Sam’s Club Health & Wellness, it is our responsibility to make a positive impact on the communities that we serve, to make quality healthcare more affordable and accessible, and to simply create opportunities for our customers and patients to live better,” stated Richard Rothman, R.Ph., director of talent acquisition–health and wellness for Walmart Stores. “Healthcare begins with the patient, and it is important to give back to the institutions that have educated our pharmacists.”

At the Development Pre-Session: Creating a Culture of Effectiveness: Integration and Communication for Developing a Culture of Philanthropy, attendees learned how to build a culture of giving that lasts a lifetime. Presenters led discussions focused on two institutional cultures: a culture of effectiveness and a culture of interaction. Brett Schott, vice president for advancement at St. Louis College of Pharmacy, kicked off the session by asking the group to think about the common language between deans and development officers. Other presenters discussed the important role of student engagement and attendees were left with a toolbox filled with resources, tactics and best practices.

There were many opportunities throughout the meeting to learn and engage, including at the Teachers Seminar, the Graduate Student Program and many other innovative sessions. “The Walmart Scholars Program meant more to me than just an opportunity to meet new people and network with other professionals—it contributed to laying the foundation for part of my career,” said Abhay Patel of Rutgers, The State University of New Jersey. “I can attest that it is almost too easy for a new graduate to become

22

ACADEMIC PHARMACY NOW 

2014 Issue 3

@drmahendrapatel @AACPharmacy pharmacists have huge opportunity to support patient safety, health outcome and save money - Walmart Snr President #PharmEd14 overwhelmed with determining where and how to establish roots, and as a result, I could not have asked for a better time and a better opportunity to participate in the Walmart Scholars Program.”

Scholar Andrea L. Brauer from the University of Hawaii at Hilo Daniel K. Inouye College of Pharmacy also took much away from the meeting’s rich programming. “The graduate student program was a wonderful hands-on activity that helped to elucidate the details of marketing myself in order to pursue a career in academia. Prior to this workshop I was unaware of developing a philosophy of teaching.”

feature story

Through strong programming and networking opportunities, AACP and Walmart’s shared goal to strengthen the skills and commitment to a career in academic pharmacy was unmistakably met and exceeded for the participating scholars. “At the end of the day, the AACP Annual Meeting has solidified my desire to enter into academic pharmacy.

Academia is a unique career path, but one that I am confident will always keep me on my toes and challenge me to grow as a professional,” said Jacyln M. Stoffel of Drake University College of Pharmacy and Health Sciences. “It was an honor to sit with educators and listen to stories of their own career paths. I can only hope that I, too, have that same passion and excitement for my career.”

In addition to programming and receptions, many scholars also found great value in the networking opportunities. JefApplication materials for the Walmart Scholars Program frey Engle of the University of Wisconsin-Madison School at the 2015 AACP Annual Meeting, July 11–15, in National of Pharmacy “found the meeting most useful for networkHarbor, Maryland, will be available late December on the ing with current academic pharmacists, residents interested AACP Web site under Career Development, then Research in academia, and student pharmacists. My faculty mentor Grants, Fellowships and Scholarship Programs, and are due was great about introducing me to faculty with whom he at AACP by 5:00 p.m. EST on Feb. 16, 2015. Questions? Conhad previously developed relationships, and he emphasized tact walmartscholars@aacp.org. the importance of making connections now for future collaborations.”

ACADEMIC PHARMACY NOW 

2014 Issue 3

23

feature story Taking Center Stage The keynote speakers at Pharmacy Education 2014 awed attendees with their combination of humor, intelligence and take-home inspiration. Opening the meeting, AACP President Peggy Piascik, Ph.D., professor in the pharmacy practice and science department at the University of Kentucky College of Pharmacy, highlighted the Association’s work in meeting the challenge she set forth while at the starting gate of her presidency a year ago, referencing her Kentucky Derby roots. Piascik applauded the key achievements of each AACP standing committee [for details, see the standing committee reports by visiting the Governance section of www.aacp.org], and generated excitement for new Association initiatives to be released soon.

Referencing the Academic Affairs Committee’s work, she said, “Educational games require students to actively learn by forcing them to make decisions for determining game strategies and solutions. The playing of games is known to stimulate curiosity and interest and also has the potential to generate enthusiasm, encourage competition, and increase student engagement.”

A Look Into the Future Piascik’s remarks set the stage for Opening General Session speaker, Dr. Ian Morrison, internationally-known author, consultant and futurist, and the anticipation amongst attendees was palpable. Morrison delivered, using his charismatic Scottish wit and humor, as he took attendees on a journey through the future of the American healthcare marketplace. He presented the political, economic and strategic context of change in healthcare, and examined how those affecting the field are preparing for its future.

He underscored the important role pharmacists will play in care coordination in the future healthcare marketplace, and how we can move from volume to value.

Addressing the healthcare access disparity, he used an example near and dear to Americans’ hearts: fast food. “You can get a cheeseburger anywhere in America at 3:00 in the morning but you can’t get primary care after 6:00 p.m.” He continued, “The healthcare value equation is value = (access + quality + security)/cost. And the U.S. needs to improve value.”

24

ACADEMIC PHARMACY NOW 

2014 Issue 3

@Ron_Jordan #PharmEd14 Dean Chase uses the three A’s, Access, Affordability, and Accountability to align all AACP efforts this year!

feature story

Riding the Waves Attendees were eager to hear President-elect Patricia A. Chase, Ph.D., professor and Gates Wigner Dean at the West Virginia University School of Pharmacy, address the three priority areas of the coming year: access, affordability and accountability. “We are in the midst of an exciting and yet challenging time—a period of momentous change in higher education and healthcare,” she said. “The changes are so great, and they are happening so quickly, that it can be difficult to process them and to respond appropriately and swiftly. In fact, ‘responding swiftly’ is often seen as an oxymoron in our profession. I believe we can do better.

“Where are the changes? I see them in three broad categories: cost, quality and access in both education and healthcare.” Mirroring Piascik’s pride in her home state, Chase referenced whitewater rafting in West Virginia as a metaphor for navigating rapid institutional change.

Big Data, Big Changes Dr. Atul Butte, chief of the Division of Systems Medicine at Stanford University, revealed to Science Plenary attendees where “big data” is leading healthcare and how clinicians can be on the frontline of using this data to improve patient care. “Behavior and environment are the ‘prescription pad of the future,’” he said. “By the end of the decade, we could be paying $33 per genome—I think I paid more for breakfast this morning!”

ACADEMIC PHARMACY NOW 

2014 Issue 3

25

feature story More than ever, technology drove discussion at the Annual Meeting.

From sessions on 3D printing to the buzz on social media, meetinggoers found more high-tech topics, and channels, on which to connect than any meeting before.

Lessons in Learning From 3D printing and virtual patients, to E-professionalism and grant writing, Pharmacy Education 2014 gave attendees countless opportunities to cultivate inspiration. Across four days of programming, meeting-goers engaged with experts, colleagues and award winners, gathering innovative practices to apply to their work.

Expanded mini-session programming gave attendees the chance to learn at their own pace while Sections and SIGs provided insight into topics such as job growth after a promotion, and the role pharmacists and law enforcement can play to prevent prescription drug abuse. The common thread running through each session was the dynamic exchange of ideas—attendees discussed and compared practices at their own institutions in an effort to bring back positive change.

26

ACADEMIC PHARMACY NOW 

2014 Issue 3

@tmpbrock @MonashUni session about simulation project with @ucsfpharmacy and UConn is great example of power of true collaboration. #PharmEd14

feature story

Outside of scheduled programming, attendees had the chance to gather in open meeting spaces, continuing discussion from previous sessions or gathering new ideas from colleagues. Attracting participants from around the world, the AACP Annual Meeting affords the best opportunity for Academy members to connect with fellow pharmacy faculty, staff and students.

ACADEMIC PHARMACY NOW 

2014 Issue 3

27

feature story

Social Strides The excitement amongst attendees at Pharmacy Education 2014 was felt both onsite and online. Social media sites provided more opportunities for engagement around the clock. Twitter, Facebook, Vine, Instagram and others were abuzz with conference activity. Launched at this year’s Annual Meeting was a mobile event app that allowed attendees to customize their schedule, join discussions with speakers and colleagues, download session materials, and much more. AACP plans to continue using the app at other meetings and events throughout the year.

To see all tweets from the meeting, search #PharmEd14 on Twitter and check out our Annual Meeting Storify: https:// storify.com/aacpharmacy/pharmacy-education-2014-theaacp-annual-meeting.

28

ACADEMIC PHARMACY NOW 

2014 Issue 3

@mikefulford #PharmEd14 what a great conference! It has been an amazing experience to connect with so many great people and have learned much!

feature story

Academy Accolades “Tonight provides an opportunity to demonstrate our relentless pursuit of excellence across the Academy,” President Piascik said as she welcomed attendees to the Closing Banquet. In addition to the vibrant learning, the Annual Meeting is a place for the profession to come together and recognize the Academy’s collective success during the past year. Exemplary teaching methods, significant strides in research and outstanding community service were just some of the reasons attendees had to celebrate in 2014. To read more about these exciting achievements, visit AACP’s Media Room: http://www.aacp.org/news/media/.

ACADEMIC PHARMACY NOW 

2014 Issue 3

29

feature story In the Market for Learning More than 40 companies and organizations exhibited at Pharmacy Education 2014, including publishers, assessment companies, retail pharmacies and more. Attendees took advantage of opportunities to learn about exhibitors’ wide range of products, tools, techniques and resources to support their work. During Exhibit Hall hours, tables were filled with impromptu networking sessions, comprised of faculty from diverse institutions, eager to continue their learning outside of the sessions.

In an unprecedented debut, AACP unveiled a new product— Mimycx, the first educational game from Professions Quest, the Association’s educational learning solutions company.

Attendees stood in line to get a glimpse of the game that provides multiple players with a virtual, team-based environment to collaborate and share knowledge and skills with other health professions students. The game is currently in Beta testing and is expected to be launched in early 2015.

30

ACADEMIC PHARMACY NOW 

2014 Issue 3

@rxJanan Millennial students love medical apps, but need to learn how to evaluate them for accuracy! #PharmEd14 @AACPharmacy

feature story

Attendees flocked to the AACP exhibit booth to experience Mimycx, the not-yet-released educational game from Professions Quest. In it, health professions students must work together in a virtual environment to diagnose and treat patients.

Save the Date Mark your calendar for the next AACP Annual Meeting, July 11–15, at the Gaylord National Resort & Conven­tion Center, National Harbor, Maryland (Washington, D.C. area). Plans are al­ready under way to make Pharmacy Edu­ cation 2015, a joint meeting of AACP and the Association of Faculties of Pharmacy of Canada, an outstanding event.

ACADEMIC PHARMACY NOW 

2014 Issue 3

31

members working for

you

Straightening the Learning Curve AACP’s scholar-in-residence focuses on the “how” of education.

By Kyle R. Bagin The Donald C. Brodie AACP Academic Scholar-inResidence program, established in 1988, provides a focused opportunity for a pharmacy faculty member to examine public policy, conduct research or analyze an issue directly related to pharmacy education or the pharmacy profession.

2014–2015 Scholar Rebecca L. Focken, Pharm.D., assistant professor of practice and IPPE director at North Dakota State University, recently completed a five-month sabbatical at AACP. Early on in her time here, she spoke to us about her Ph.D. focus on adult and occupational education and how the Washington, D.C. area stacked up against her home in Fargo.

Special Delivery

Q. Why do you feel that this is an important issue in pharmacy education?

Q. What is adult and occupational education?

A. Adult and occupational education is basically how adults learn, and how adults learn in their workplace environments.

A. I think it can be tempting for programs to focus primarily on covering required curricular content rather than also focusing on the actual delivery of content and higher level assessments of learning. In higher education, educational programs are built primarily around required content. That’s very important and it’s necessary to have content experts, but it’s also important to make sure that programs are delivering content in a way that is going to be most effective for learning; whether the learning is occurring in the didactic setting or during experiential education.

Road Work Ahead Q. What do you hope to accomplish during your time as the Brodie Scholar?

A. Currently, I am in the process of working on my Ph.D. in adult and occupational education, so right now my purpose is to begin exploring how programs can best approach teaching and assessing problem solving within pharmacy education.

Q. How will your work here benefit pharmacy education?

A. Pharmacy educators are content experts who have multiple responsibilities competing for their

32

ACADEMIC PHARMACY NOW 

2014 Issue 3

F

Faculty News

Faculty News time: teaching, research, practice, and service. Everyone wants their students to learn, that’s the goal, but not everyone has content expertise in the discipline of education. My work here will allow me to combine my pharmacy expertise with what I’ve learned about adult and occupational education to explore problem solving in pharmacy education from a new perspective.

My hope is that I’ll be able to say, “Right now in the literature, this is what seems to work best, these are things we’ve tried, and this is what we haven’t tried yet.” Then, I think as pharmacy educators, we can make more informed choices about how we choose to teach and evaluate problem solving in our teaching environments.

Home, Sweet Home Q. What’s the biggest difference between Fargo and the D.C. metro area?

A. There are a lot of differences, I’ll say that. I love the smallness of the Fargo-Moorhead area and the connection that people have within the state. As far as differences go, it’s certainly larger. I’ve lived in lots of places from small towns to large cities, but ironically, here I have the shortest commute I’ve ever had!

Q. Any differences, professionally-speaking?

A. The profession of pharmacy really works together in North Dakota. I feel like everybody, whether it be the college, the board of pharmacy, or the state pharmacy association, is always reaching for the same goal, which is to ensure that our students and pharmacists have the training and resources necessary to provide excellent patient care. People are very friendly here. Although it’s a larger community, it still feels like I’m working with people who are after the same interests. So in that respect, it’s not different.

Kyle R. Bagin is Communications Coordinator at AACP; kbagin@aacp.org

Albany College of Pharmacy and Health Sciences Appointments/Elections

• Gregory Dewey was named president of the Albany College of Pharmacy and Health Sciences.

Auburn University

Appointments/Elections

• Channing Ford, assistant director, Office of Teaching, Learning & Assessment • Nancy Merner, research assistant professor, Department of Drug Discovery and Development • Katelin Lisenby, assistant clinical professor, Department of Pharmacy Practice • Kaitlin McGinn, assistant clinical professor, Department of Pharmacy Practice • Michael J. Scalese, assistant clinical professor, Department of Pharmacy Practice • Nicole Slater, assistant clinical professor, Department of Pharmacy Practice • Dan Surry, associate dean for curriculum & assessment

Grants

• Angela Calderon received $10,000 in funding from the Egyptian Cultural and Education Bureau for graduate student research support.

• Richard Hansen was awarded a $63,000 contract from the University of North Carolina at Chapel Hill to assist on a grant from the Agency for Healthcare Research Quality. Hansen will study the continuity of medication management in Medicaid.

• Peter Panizzi received $74,000 in funding from the Massachusetts General Hospital for “Pathogen-Specific Imaging of Endocarditis.” He also received $33,000 in funding from Vanderbilt University to collaborate on a NIH grant to study the mechanism of staphylocoagulase-activated blood clotting.

California Northstate University Appointments/Elections

• Eman Atef, associate professor • Yvette Crockell, associate professor, director of APPEs • Carol Millette-Snodgrass, assistant professor, director of IPPEs

Grants

• Ruth Vinall, $10,000 from the Asian American Network for Cancer Awareness, Research and Training, “Reducing Cancer Disparities Among Asian Americans”

Promotions

• Leanne Coyne, associate professor • Parto Khansari, associate professor • Tibebe Z. Woldemariam, associate professor

ACADEMIC PHARMACY NOW 

2014 Issue 3

33

faculty news Drake University

Appointments/Elections

• John Harrell, assistant professor of health sciences • Kelly M. Percival, assistant professor of infectious disease

Awards

• Ginelle Bryant, Faculty Preceptor of the Year • Brian Gentry, 2014 CPHS Mentor of the Year • Abebe E. Mengesha, 2014 CPHS Teacher of the Year • Charles R. Phillips, Granberg Professional Leadership Award • Robert P. Soltis received the Hartig Distinguished Professor, and Ellis and Nelle Levitt Distinguished Professorship awards.

Grants

• Michael T. Andreski. Source: Iowa Pharmacy Association, $10,000. Title: Research Portion of Iowa New Practice Model Pilot Project.

• Renae J. Chesnut, $20,000 for Entrepreneurial Leadership Summer Internship Program Pharmacists Mutual; $5,000 for Entrepreneurial Leadership Summer Internship Program Target; $3,000 for Next Top Entrepreneur Competition • Brian Gentry: ISGC Base Program, 3 years. Title: Infection Mitigation During Space Flight: Combination Pharmacotherapy to Combat Herpes Viral Infections, Curtail Drug Resistance, and Decrease Incidence Rates of Adverse Effects. He also received $15,000 from the Iowa NASA EPSCoR for “Pharmacological Enhancement of Anti-Viral Chemotherapy for the Treatment of Herpes Virus Infections.”

• Abebe Mengesha and Pramod B. Mahajan, Principal Investigators. Title: Impact of Nanotechnology in Design and Development of Triggerable Drug Delivery Systems for Smart Medicine Sponsor: Iowa NASA EPSCoR; Duration: Jan. 2014–Dec. 2014 Direct cost: $15,000.

Promotions

• Andrew R. Miesner, associate professor of pharmacy practice, College of Pharmacy and Health Sciences • Denise A. Soltis, associate professor of pharmacy practice, College of Phar-

34

ACADEMIC PHARMACY NOW 

macy and Health Sciences • Nora L. Stelter, associate professor of pharmacy practice, College of Pharmacy and Health Sciences

Duquesne University Appointments/Elections

• Janet K. Astle has been appointed assistant dean for student services.

• Jordan R. Covvey, assistant professor • Thomas J. Falcione has been appointed director of experiential education.

• Anthony J. Guarascio, assistant professor • Bruce H. Livengood will be appointed assistant dean for professional programs.

• Marsha McFalls was appointed a committee member of both the ABLE and Gateway Examination Subcommittee of the Assessment Committee 2014-2015, and University Educational Technology Committee 2014–2015.

She was appointed committee chair of the Pharmacy Educational Technology Committee 2014–2015.

Awards

• Janet K. Astle, Duquesne University Creative Teaching Award • Jennifer P. Elliott was awarded the 2014 Presidential Scholarship Award.

• Andrew Gaiser received the Liberal Arts Endowed Fellow Award, April 2014.

• Bruce H. Livengood and Janet K. Astle received academic affairs awards at Duquesne’s annual assessment brunch.

• Darlene Monlish has been awarded a 2013–2014 Distinguished Dissertation Award for her dissertation, “ge-related effects on the mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in breast cancer and the characterization of novel MEK5 inhibitors.”

• Lauren O’Donnell, Duquesne University Creative Teaching Award • Christine O’Neil, Duquesne University Creative Teaching Award • Michael Perry received the Duquesne University Creative Teaching Award.

He was also awarded the Duquesne University Celebration of Teaching Excellence 2014 Award.

• The American Public Health Association has awarded the Center for

2014 Issue 3

Pharmacy Care Pharmacist Clinical Team (Suzanne Higginbotham, Robert Laux, Monica L. Skomo) for Outstanding Business Practice Model.

Grants

• Carl Anderson has received a $10,000 grant from Strategic Process Control Technologies for a project modeling drug risk assessment and simulation development. This brings the total amount to date to $165,000.

• Ira Buckner received a $4,000 from Lipella Inc., for student support in conducting research.

• Jane Cavanaugh has received a research grant in the amount of $394,234 from the National Institutes of Health’s National Cancer Institute for “Novel Small Molecule Inhibitors of MEK5_ERK5 for the Treatment of Breast Cancer.”

• Aleem Gangjee recently received $506,757, for year two of an award from the National Institutes of Health, National Cancer Institute for Purine Synthesis Inhibitors with Selective Folate Receptor Tumor Transport. This brings the total award amount to date to $1,090,535.

He also received $169,805 in additional year four funding for a subcontract from Wayne State University on a grant from the National Institutes of Health, National Cancer Institute, for “Discovery of Novel PCFT Targeted Agents.”

This brings the total award to date to $737,420. Additionally, Gangjee received $342,672 in additional funding for the year three award from the National Institutes of Health, National Institute of Allergy and Infectious Diseases, for “Pneumocystis Jirovecii Targeted Antiopportunistic Agents.” This brings the total award to date to $1,081,322.

• Jelena Janjic co-received a Provost’s Interdisciplinary Research Consortia Grant, the first in a series of such grants to provide University funding for interdisciplinary research and scholarship.

• Robert L. Maher Jr. has received a $2,500 grant from the National Association of Chain Drug Stores Foundation to develop a patient-focused research project in a community pharmacy setting.

• Jamie McConaha received $10,000, from Pfizer Inc., for a smoking cessation program titled Courage to Quit.

This brings the total award amount to date to $20,000.

faculty news • Lauren O’Donnell has received a $10,000 research grant. The Faculty Development Fund award was given for Protecting the Neonatal Brain: Conflicting Roles for Innate and Adaptive Immunity in Pediatric Infection. The period of the award extends through April 30, 2016.

• Kevin Tidgewell has received a $392,796 grant from the National Institutes of Health’s National Center for Complementary and Alternative Medicine, to be used for a project titled Cyanobacterial Natural Products to Treat Comorbid Pain and Depression.

• Peter Wildfong received $10,000 from Boehringer Ingelheim Pharmaceuticals Inc.

Mercer University

Appointments/Elections

• Annesha W. Lovett was appointed to the editorial board of Medicine.

Grants

• Ajay K. Banga was awarded a $45,000 grant for “Use of polyvinyl alcohol in transdermal patches” from Merck Millipore.

• Michell B. Butler was awarded the 2014–2015 National Association of Chain Drug Stores Foundation Faculty Scholars program grant of $2,500.

Retirements

• Stanley H. Pollock, professor

Midwestern University/ Downers Grove Appointments/Elections

• Robert Chapman has been appointed to the American Association of Pharmaceutical Scientists president’s task force on research funding and resources and represents the Drug Discovery and Development Interface section on the AAPS Awards Committee. He has also been elected member-at-large on the Executive Council, American Association of Pharmaceutical Scientists.

• Jen D’Souza, editorial board, Pharmacy Today • Jacob P. Gettig has been named chair, Continuing Professional Education Section for AACP. • Spencer E. Harpe has been appointed associate editor (term 2014–2016) for the Journal of the American Pharmacists Association.

• Karen M. Nagel-Edwards is now the chair-elect for the AACP Teachers of Pharmaceutics Section.

• Ana C. Quinones-Boex has been named secretary, Social and Administrative Sciences Section, AACP. • Robin M. Zavod serves as the vice chair of the DDDI section and is the DDDI section representative on the Publications Committee. She is also chair of the basic Pharmaceutical Sciences Section, American Pharmacists Association Annual Meeting. Additionally, she has been appointed immediate past chair, Council of Faculties, AACP.

Awards

• Regina Arellano is now a board certified pharmacotherapy specialist.

• Sally Arif has been awarded an American Heart Association grant of $4,500 for “Cardiovascular and Diabetes Screening Program for the MiddleEastern Community of Chicagoland.”

• Krystina Geiger is now a board certified pharmacotherapy specialist.

• Elise Gilbert is now a board certified pharmacotherapy specialist.

• Anil Gulati was awarded the Paul R. Dawson Biotechnology Award at the AACP Annual Meeting.

• Spencer E. Harpe received the Innovations in Teaching Award at the AACP Annual Meeting.

• Anna Kabakov is now a board certified pharmacotherapy specialist.

• Adam Linstedt is now a board certified pharmacotherapy specialist.

• Julio Rebolledo has been nominated as a regional cluster coach for the Patient Safety and Clinical Pharmacy Services Collaborative 6.0.

• Timothy J. Todd has been awarded fellow status by the Pediatric Pharmacy Advocacy Group.

• Justin Wrin is now a board certified pharmacotherapy specialist.

Grants

• Anil Gulati, Tian Medical, Inc. grant, $75,926, “Regulation of Blood Brain Barrier by Sphenopalatine Ganglion.”

• Marc Scheetz, National Institutes of Health R15 grant, $458,764, “Elucidation of an informed drug dosing scheme to minimize kidney injury.”

He also received grants from JMI Labs

($1,430 for “Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) Surveillance Program for 2014”) and Cubist Pharmaceuticals ($10,479 for “Beyond Benchmarking: Evaluation of Carbapenem utilization in a national Network”).

Promotions

• Sally Arif, associate professor and awarded tenure • Mary Ann Kliethermes, professor • Christie Schumacher, associate professor

Northeastern University Appointments/Elections

• Becky Briesacher, associate professor • John Devlin has been appointed acting chair of the Department of Pharmacy Practice.

• Gregory Miller, associate professor • Roman Manetsch, professor • Jack Reynolds has been appointed as acting vice provost for undergraduate education.

• David Zgarrick has been appointed to serve as acting dean of the School of Pharmacy.

Grants

• Mansoor Amiji, awarded $427,625 from the National Institutes of Health for his work, “Targeted Platinates/ siRNA Combination Therapy for Resistant Lung Cancer;” and awarded a $50,000 Northeastern University Tier-1 Grant for his work, “A Cyber-Physical Platform for Rapid Development of Nano-Delivery Systems.”

• Heather Clark, awarded $1,641,973 from NIH/NINDS (R01) for her work, “Polymer-Free Nanosensors for Monitoring Biochemical Dynamics in Dendritic Spines” and awarded $250,000 from an Anonymous Corporate Grant for her work titled “The NanoClinical Analyzer.”

• Jennifer Morales, a graduate student in Heather Clark’s lab, was awarded a $44,000 National Science Foundation Graduate Research Fellowship for her work, “Fluorescent DNA-Dendrimer Nanosensors for Dopamine Sensing.”

• Roger Edwards, awarded $38,585 in supplemental contracts from the Massachusetts Department of Public Health/ Adcare Educational Institute of Mas-

ACADEMIC PHARMACY NOW 

2014 Issue 3

35

faculty news sachusetts for his work, “Becoming Baby Friendly Technical Assistance Project” and awarded a $7,000 subcontract from Tufts 2013 Innovations in Education Intramural Grant Program for his work, “Improving Medical Student Training in Lactation Practices through an Interactive Computer-Based Curriculum for Medical Students.”

• Roger Giese, awarded $1,234,100 from the National Institute of Environmental Health Sciences for his project, “Discovery of Xenobiotics Associated with Preterm Birth.”

• Torbjorn U.C. Jarbe, awarded $229,891 by the National Institutes of Health for his work, “Endogenous/Exogenous Cannabinoids: A Comparison.”

• Alexandros Makriyannis, awarded $483,515 by the National Institutes of Health for his work, “Molecular Basis of Cannabinoid Activity.”

• Spiro Pavlopoulos, Kumara Subramanian, and Jay West, awarded $193,125 by the National Institutes of Health for their work, “Novel Probes for N-acylethanolamine-hydrolyzing acid amidase function.”

• Steven Pizer, awarded $78,256 by the VA Boston Healthcare System for his work, “Instructor and Technical Consultant to Health Care Financing & Economics group at VA Boston/South Huntington.”

• Christopher Skipwith, awarded a $41,500 Ford Foundation Postdoctoral Fellowship from The National Academies and awarded a $92,000 Postdoctoral Science Research Fellowship from UNCF/Merck Science Initiative for his work, “A Platelet MimeticBased Approach to Detect Markers of Restenosis.”

• Vladimir Torchilin, awarded $372,034 from the National Institutes of Health for his work, “Multifunctional matrix metalloprotease-2-sensitive anti-cancer nanopreparations.”

Promotions

• Carla Bouwmeester, associate clinical professor • Margarita DiVall, clinical professor

Retirements

• Richard C. Deth, professor of neuropharmacology, Department of Pharmaceutical Sciences

36

ACADEMIC PHARMACY NOW 

Northeast Ohio Medical University Appointments/Elections

• Louis D. Barone has been appointed to the American Society of Health-System Pharmacists Section of Pharmacy Informatics and Technology’s Executive Committee to the Section Advisory Group on Professional Development for the 2014–2015 term.

• Adeline Bertola has been appointed assistant professor of pharmaceutical sciences.

• Jaclyn Boyle has been appointed assistant professor of pharmacy practice.

• Susan P. Bruce has been named associate dean for pharmacy education and interprofessional studies. She is also the chair and professor of pharmacy practice.

• Hui Li has been appointed research assistant professor of pharmaceutical sciences.

• Timothy R. Ulbrich has been named associate dean for workforce development and practice advancement.

• Scott S. Wisneski has been appointed chair of the Awards Committee for the AACP Experiential Education Section.

Awards

• Timothy R. Ulbrich was selected a 2014–2015 AACP Academic Leadership Fellow. He was also selected as a 2014 Greater Akron Chamber 30 for the Future award recipient.

Grants

• Charles Kunos, Moses O. Oyewumi and Werner J. Geldenhuys were awarded $18,000 from the Atwood Foundation to support “Timing of RNR Inhibition in Cervix Cancer Treatment.”

Promotions

• Seth P. Brownlee has been named associate dean for assessment.

Pacific University Oregon Appointments/Elections

• John E. Begert, PGY2 resident • Reza Karimi was selected and named dean.

• Stephanie J. Kory, assistant professor in pharmacy practice • Muhammed Quiros, PGY2 resident • Edward M. Saito, assistant professor in pharmacy practice

2014 Issue 3

Grants

• Fawzy Elbarbry received $30,000 from the Collins Medical Trust Research for investigating the anti-hypertensive effect of thymoquinone.

Promotions

• Jeff Fortner, associate professor • Sarah E. White, associate professor

Purdue University

Appointments/Elections

• Judy T. Chen was elected as a distinguished practitioner & fellow in the Pharmacy Academy of the National Academics of Practice.

• Dan Degnan was selected as the president-elect of the Indiana Pharmacists Alliance for 2015.

• Jasmine D. Gonzalvo was elected to the board of directors for the American Association of Diabetes Educators.

• Carol B. Post was selected as the president-elect of The Protein Society.

Awards

• Jessica Ho was chosen as a recipient of the Indiana Society of Health System Pharmacists Resident of the Year.

• Lynne S. Taylor was selected to receive the 2014 Craver Award from the Coblentz Society.

• The Purdue Pharmacy Kenya Program Team (Ellen M. Schellhase, Sonak Pastakia, Monica L. Miller and Rakhi Karwa) was selected as a regional winner for the C. Peter Magrath Engagement Award by the Association of Public and Land-Grant Universities.

Grants

• Julie D. Bolinger received $1,100 from Fred Run Ltd. for “Pharmacy Diabetes Education Program.”

• Stephen R. Byrn received $129,732 from National Institute for Pharmaceutical Technology and Education for “Study on Evaluation of Drug Product Formulation In Vitro Performance Characteristics Related to Abuse-Deterrence.”

• Noll L. Campbell received $12,601 from Indiana University for “Optimistic.” Additionally, she received $152,466 and $728,493 from PHS-NIH National Institute on Aging for “Evaluating the Adverse Cognitive Effects of Medications;” and $23,427 from Indiana University for “Dissemination of the

faculty news Aging Brain Care Program.”

• Noll L. Campbell and Zachary A. Weber received $59,558 from Regenstrief Institute Inc. for “Medication Adherence in Older Adults with Multiple Co-morbidities and Cognitive Impairments.”

• Vincent J. Davisson received $3,348 and $7,972 from AsedaSciences GmbH for “Method Implementation for Intracellular Cell Markers.” He also received $130,480 from Leidos for “Raman Active Dyes.”

• Ryan M. Drenan received $1,677,829 from National Institutes of Health for “Nicotinic Acetylcholine Receptor Function in the Mesolimbic Dopamine System.”

• Robert L. Geahlen received $332,939 from PHS-NIH National Institute of Allergy and Infectious Diseases for “Tyrosine Kinases and Lymphocyte Activation.”

• Arun K. Ghosh received $195,139 from Wadsworth Center Health Research Inc. for “Inhibition and Mechanism of Flavivivus Methyltransferase.”

• Arun K. Ghosh received $320,560 from Kumamoto University for “Design and Synthesis of Small-Molecule CCR5 Antagonists.”

• Richard A. Gibbs received $36,400 from Syracuse University for “Investigation of Ghrelin O-Acyltransferase as a Target for Treating Hyperphagia in Prader-Willi Syndrome.”

• Marlene O. Heeg received $325,000 from Sunovion Pharmaceuticals Inc. for “PeerView Live, Major Depressive Episodes Associated with Bipolar Disorder: How Can Diagnosis and Management Be Improved in the Primary Care Setting?”

• Marlene O. Heeg received $83,890 from Abbvie Inc. for “PeerView in Practice, Optimizing the Clinical Use of Biologics in Rheumatoid Arthritis: a Case Based Approach to the Assessment of Disease Activity and Response to Therapy.”

• Marlene O. Heeg received $241,810 from Incyte Corporation for “The Hematology-Oncology Team in Myelofibrosis: Best Practices for Therapy and Strategies for Enhancing Patient Care.”

• Marlene O. Heeg received $50,000 from Lilly (Eli) and Company, $30,000 from

Astrazeneca Product Development, and $75,000 from Bristol-Myers Squibb Company for “A 2014 National Educational Initiative on Therapeutics & Rheumatology for Rheumatology State Societies.”

• Marlene O. Heeg received $125,000 from Allergan for “Identifying and Treating Chronic and Episodic Migraine: Clinical Pearls for Diagnosis and Preventive Management.”

• Marlene O. Heeg received $200,000 from Takeda Pharmaceutical International Inc. U.S. Region and $10,000 from Given Imaging Inc. for “2014 National Inflammatory Bowel Disease Educational Initiative.”

• Marlene O. Heeg received $50,000 from Teva Pharmaceuticals, USA for “Asthma Supplement-Family Practice News and Internal Medicine News.”

• Marlene O. Heeg received $100,000 from Ortho-McNeil Janssen Science Affairs LLC. for “2014 Educational Initiative.”

• Marlene O. Heeg received $100,000 from Janssen Johnson & Johnson Services, Inc. for “2014 ARTHROS Educational Initiative.”

• Marlene O. Heeg received $10,000 from Prometheus Laboratories Inc. for “2014 National IBD Educational Initiative.”

• Marlene O. Heeg received $5,000 from Prometheus Laboratories Inc. and $25,000 from Genentech Corporation, Inc. for “Melanoma in Focus: Tailoring Novel Therapy to Optimize Patient Outcome and Exploring the Potential Emerging Agents.”

• Marlene O. Heeg received $100,000 from Novartis Pharmaceuticals Corporation for “PeerView inReview, Fostering Collaboration Between Primary and Secondary Care in the Treatment of MS: Considerations for the Management of Disease-Related Symptoms.”

• Marlene O. Heeg received $342,013 from Takeda Pharmaceutical International Inc. U.S. Region for “CGA-2014IBD, 2014 ACG Trial by Jury.”

• Marlene O. Heeg received $60,000 from Astellas Pharma U.S. Inc. and $80,480 from Novartis Pharmaceuticals Corporation for “The Role of Allied Healthcare Professionals in Maintenance Immunosuppression for Renal Transplantation: Improving Adherence, Improving Outcomes.”

• Marlene O. Heeg received $15,000 from Salix Pharmaceuticals, Inc. and $2,500 from Prometheus Laboratories Inc. for “2014 ROME Foundation Update from Digestive Disease Week (DDW).”

• Marlene O. Heeg received $33,890 from Eli Lilly and Company and $50,000 from UCB Inc. for “Optimizing the Clinical Use of Biologics in Rheumatoid Arthritis: A Case-Based Approach to Assessment of Disease Activity and Response to Therapy.”

• Marlene O. Heeg received $169,360 from Teva Pharmaceuticals, USA for “Maintaining Adherence to Disease Modifying Therapy in Patients with Multiple Sclerosis: Important Factors and Strategies.”

• Marlene O. Heeg received $50,000 from Janssen Johnson & Johnson Services, Inc. for “Optimizing Strategies with IBD Therapies.”

• Marlene O. Heeg received $134,885 from Bayer HealthCare, LLC for “PeerView InReview, Assessing the Clinical Potential of Emerging Targeted Agents in Advanced, Differentiated Thyroid Cancer.”

• Marlene O. Heeg received $220,000 from Janssen Johnson & Johnson Services, Inc. for “Psoriasis Clinical Review and Visiting Professorship Program.”

• Marlene O. Heeg received $55,000 from Teva Pharmaceuticals, USA for “PeerView inExchange, the Present and Future of Individualized Management of Metastatic CRPC: Expert Perspectives on the Challenges, Opportunities and Practicalities.”

• Marlene O. Heeg received $2,000,000 from Salix Pharmaceuticals, Inc. for “2013–2014 Hepatology Centers of Educational Expertise He National Educational Initiative.”

• Marlene O. Heeg received $75,000 from Genentech Corporation, Inc. for “Assessing the Future of Therapy for B Cell Malignancies.”

• Marlene O. Heeg received $50,000 from Celgene Corporation for “Peerview InReview, New Targets and Novel Options in the Management of Mantle Cell Lymphoma: An Increasing Role for Innovative Therapy?”

• Karen S. Hudmon received $1,624,203 from National Institutes of Health

ACADEMIC PHARMACY NOW 

2014 Issue 3

37

faculty news for Standardized Patients to Assess Competency in Tobacco Cessation Counseling.

• Deanna S. Kania received $50,000 from the Department of Veterans Affairs for “Utilization of a Tertiary Patient Aligned Care Team (PACT) to Facilitate Communication to Primary Care Physicians (PCPs) in Surrounding Rural Communities on Multidisciplinary Care of Persons with HIV.” • Michael B. Kays received $35,000 from American Society for Clinical Pharmacology & Therapeutics for “Population Pharmacokinetics and Pharmacodynamics of Linezolid in Obese and NonObese Patients.”

• Gregory T. Knipp received $70,000 from Phytoption LLC for “Evaluating New Pharmaceutical Excipients for Dissolving Poorly Water-Soluble Drugs.”

• Michael D. Murray received $28,000 from Regenstrief Institute for Health Care from “Regenstrief Institute Data Core.” He also received $8,812 from Indiana University for “The Natural History of Schizophrenia in a Geographically-Defined Population.”

• Brian R. Overholser received $138,217 from PHS-NIH National Heart, Lung & Blood Institute for “Probing the Atrial Arrhythmogenic Substrate with Sustained Adrenergic Stimulation.”

• Brian R. Overholser, Wanqing Liu and James E. Tisdale received $5,000 from American College of Clinical Pharmacy for “MicroRNA 362-3p Expression During Heart Failure: a Novel Biomarker to Predict QT Interval Prolongation Sensitivity.”

• Laurie L. Parker received $325,528 from PHS-NIH National Cancer Institute for “Bio-sensor Assay to Screen for Signaling Pathway Inhibition in Cancer.”

• Sonak D. Pastakia and Rakhi Karwa received $15,400 and $14,300 from Moi University for “Pharmacovigilance (PV) in a Resource Limited Setting: Approaches to Targeted Spontaneous Reporting for Suspected Adverse Drug Reactions to Antiretroviral Treatment.”

They also received $25,765 from Indiana University for “AMPATH Plus.”

• Rodolfo Pinal received $50,000 from National Science Foundation for “From Compacts to Integrated Systems: a New

38

ACADEMIC PHARMACY NOW 

Paradigm for the Design and Manufacture of Pharmaceuticals;” $35,000 from Astrazeneca Pharmaceuticals LP and $35,000 from Abbvie Inc for “Center for Pharmaceutical Processing Research Consortium.”

• Jean Christopher Rochet received $100,000 from Branfman Family Foundation for Alpha-Synuclein-Peptide Interactions at the Membrane Surface: Role in Parkinson’s Disease. He also received $77,000 from PHS-NIH National Institute of Environmental Health Science for “PhIP-Induced Neurodegeneration: Mechanisms and Relevance to Parkinson’s Disease.”

• Daniel T. Smith received $333,507 from PHS-NIH National Institute Neurological Disorders and Stroke for “Role of Acrolein in Spinal Cord Injury.”

• Lynne S. Taylor received $170,000 from National Institute for Pharmaceutical Technology and Education for “Further Development of Nonlinear Optical Imaging for Sensitive Detection of Crystallinity in Amorphous Formulations;” $60,000 from Merck Sharp & Dohme Corp for “Study Agreement;” and $60,000 from Merck & Company Inc. for “Studies on Amorphous Solid Dispersion Aqueous Suspensions.”

• Elizabeth M. Topp received $120,277 from Abbvie Inc. for Development and Validation of Analytical Methods for Detection and Quantitation of Surfactant Proteins in Survanta.”

• Elizabeth M. Topp, Markus A. Lill and Chiwook Park received $297,836 from PHS-NIH National Institute of General Medical Science for “Protein Aggregation in Amorphous Solids.”

• Richard M. Van Rijn received $27,208 and $248,999 from the National Institutes of Health for “Development of a Pre-Clinical Candidate for the Treatment of Alcoholism.”

• Val J. Watts received $27,654 from Army Natick Research & Development Laboratories for “Novel Vector Control Solutions for Protecting Health of U.S. Military.” He also received $260,639 from PHS-NIH National Institute of Mental Health for “Understanding Adaptive Signaling of Neuronal Adenyly Cyclases Using Sirna.”

• Michael K. Wendt received $223,677 from National Institutes of Health for

2014 Issue 3

“Targeting FGR to Prevent the Outgrowth of Metastatic Breast Cancer.”

• Yoon Yeo received $94,794 from National Science Foundation for “Faculty Early Career Development (CAREER): Osmolyte-Guided Nanoparticle Transport for Effective Drug/Gene Delivery Across the Mucosal Barriers.”

• Yoon Yeo and Raymond E. Galinsky received $361,350 and $1,408,950 from PHS-NIH National Institute of Biomedical Imaging & Bioengineering for “Environmentally-Adaptive Nanoparticles with Focal Irradiation for Cancer Therapy.”

Promotions

• Greg Hockerman was promoted to full professor of medicinal chemistry and molecular pharmacology.

• Kellie (Jones) Weddle was promoted to clinical professor of pharmacy practice.

• Monica L. Miller was promoted to clinical associate professor of pharmacy practice.

• Ellen M. Schellhase was promoted to clinical associate professor of pharmacy practice.

Presbyterian College Appointments/Elections

• Serge Afeli has been named assistant professor of pharmaceutical and administrative sciences.

• Mandy Funderburk has been named director of assessment.

• Nancy H. Goodbar has been elected president-elect of the South Carolina Society of Health Systems Pharmacy.

• Kayce M. Shealy has been selected as speaker-elect of the South Carolina Pharmacy Association.

• Nancy Taylor has been named assistant professor of laboratory education.

Awards

• Jennifer N. Clements was selected as the 2014 School of Pharmacy Teacher of the Year.

• C. Eugene Reeder received the 2014 South Carolina Bowl of Hygeia from the South Carolina Pharmacy Association.

Grants

• Alfonso Romero Sandoval, National Institutes of Health. $330,844, “Cell directed therapy using nanotechnology for the prevention of postoperative pain.”

faculty news Roosevelt University Appointments/Elections

• Subrata Deb, assistant professor of pharmacology, biopharmaceutical sciences • Cheryl L. Hayes, assistant director, experiential education • Jucimara Markoff, clinical instructor • Claudia Muldoon, experiential education coordinator, experiential education

Samford University Appointments/Elections

• Michael A. Crouch has been named dean of Samford University’s McWhorter School of Pharmacy.

Awards

• Marshall E. Cates, Margaret Self Propst Pharmacy Teacher of the Year • B. DeeAnn Dugan, Faculty Preceptor of the Year • Jeffrey A. Kyle, Pharmacy Practice Faculty of the Year • Bruce A. Waldrop, Pharmaceutical, Social & Administrative Sciences Faculty of the Year

Grants

• B. DeeAnn Dugan, $124,985, Community Foundation of Greater Birmingham, Diabetes Intervention

Promotions

• John Arnold, promoted to associate professor and granted tenure • Amy E. Broeseker, promoted to full professor • Erika M. Cretton-Scott, promoted to associate professor and granted tenure • Danielle L. Cruthirds, granted tenure • Michael Hogue, promoted to full professor • Maisha K. Freeman, promoted to full professor

Shenandoah University Appointments/Elections

• Deepak Bhatia has been appointed as assistant professor in the Pharmacogenomics Department. (Ashburn Campus).

• Kacey Carroll has been appointed as assistant professor in the Department of Pharmacy Practice. (Winchester Campus).

• Amber Darr has been appointed as assistant professor in the Pharmacogenomics Department. (Ashburn Campus).

• Teresa M. Elsobky has been appointed as Assistant Professor in the Pharmacogenomics Department. (Ashburn Campus).

• David Matthews has been appointed as assistant professor in the Department of Pharmacy Practice. (Winchester Campus).

• Isha Patel has been appointed as assistant professor in the Biopharmaceutical Sciences Department. (Winchester Campus).

• Teresa A. Schweiger has been appointed as the assistant dean for assessment.

• Jennifer Sorah has been appointed as assistant professor in the Department of Pharmacy Practice. (Winchester Campus).

• Ranjani Varadarajan has been appointed as assistant professor in the Pharmacogenomics Department.

(Ashburn Campus).

Promotions

• Jeremy R. Fox has been promoted to associate professor in the Department of Pharmacy Practice. (Winchester Campus).

• Amanda M. Munson has been promoted to associate professor in the Pharmacogenomics Department.

(Ashburn Campus).

• Tracy Nickola has been promoted to associate professor in the Pharmacogenomics Department. (Ashburn Campus).

• Michelle Rager has been promoted to associate professor in the Department of Pharmacy Practice. (Winchester Campus).

Southern Illinois University Edwardsville Appointments/Elections

• Maithili Deshpande, assistant professor health outcomes; joint position with the Southern Illinois University School of Medicine Center for Clinical Research • Jared Sheely, clinical assistant professor, internal medicine

Awards

• Ronald Worthington received two U.S. Patents (#8,563,293 and 8,679,821) for processes involving the prevention of bacterial contamination in industrial processes using natural protein native nisin.

• Southern Illinois University Edwardsville School of Pharmacy was one of four training sites selected by the American Society of Health-System Pharmacists Research and Education Foundation for the 2014 Pain and Palliative Care Traineeship program.

Christopher M. Herndon is the faculty lead for the SIUE campus training site.

Promotions

• Cassandra Maynard, clinical associate professor • Miranda J. Wilhelm, clinical associate professor

Southwestern Oklahoma State University Appointments/Elections

• Melanie K. Claborn joined the Pharmacy Practice Department as an assistant professor of pharmacy practice.

• Kalie Kerth joined the rural health program as a rural health clinical pharmacist.

Awards

• Faruk Khan completed the AACP 2013–2014 Academic Research Fellows Program and is now an Academic Research Fellow.

Promotions

• Erin D. Callen was promoted to professor of pharmaceutical sciences.

• Tiffany L. Kessler was promoted to associate professor of pharmacy practice with tenure.

• Tami Moser was promoted to associate professor of pharmaceutical sciences

Retirements

• Richard Stowe will retire effective August 1, 2015. He is an assistant professor of pharmacy practice and has served as a faculty member at the Southwestern Oklahoma State University College of Pharmacy since 2006.

St. Louis College of Pharmacy

Appointments/Elections

• The St. Louis College of Pharmacy has

ACADEMIC PHARMACY NOW 

2014 Issue 3

39

faculty news selected Bruce Canaday to serve as its 15th dean.

Sullivan University

Awards

Appointments/Elections

• Amanda N. Jett, assistant professor clinical and administrative sciences • Lourdes Ramos, assistant professor clinical and administrative sciences • Catherine A. Spencer, assistant professor clinical and administrative sciences • Cindy D. Stowe, dean and professor

Promotions

• David Cleary, associate professor (from assistant), pharmaceutical sciences • Stacy L. Rowe, associate professor (from assistant), clinical and administrative sciences, and director of student affairs (promotion to DSA)

The Ohio State University Grants

• Amanda M. Singrey has been awarded a 2013–2014 American Society of Health-System Pharmacists Foundation Pharmacy Resident Practice-Based Research Grant.

The University of Arizona Appointments/Elections

• Brian L. Erstad was selected as a master of critical care medicine by the Council of the Society of Critical Care Medicine.

• Maryam T. Fazel has joined faculty as an assistant professor in the Department of Pharmacy Practice and Science.

• Daniel C. Malone has been selected at president-elect for the International Society for Pharmacoeconomics and Outcomes Research. He will serve as president-elect from 2014–2015, president from 2015–2016 and pastpresident from 2016–2017.

• Shanna O’Connor joined the College of Pharmacy as an assistant professor in the Department of Pharmacy Practice and Science.

• Aikseng Ooi, assistant professor in the Department of Pharmacology and Toxicology • Hanna Phan has been elected as director-at-large of the executive board of directors at the Pediatric Pharmacy Advocacy Group. Her term is from 2014–2017.

40

ACADEMIC PHARMACY NOW 

• Theodore G. Tong, selected as honorary president, American Pharmacists Association • Janet Cooley received the Albert E. Rosica, Jr. Memorial Award given by the American College of Apothecaries.

• Lisa W. Goldstone and Elizabeth HallLipsy received the Original Research Award from the College of Psychiatric and Neurologic Pharmacists.

• Jeannie K. Lee received the Excellence in Geriatric Pharmacy Practice Award from the Commission for Certification in Geriatric Pharmacy Practice.

• John Murphy received the 2014 Harvey A. K. Whitney Award given by the American Society of Health-System Pharmacists.

• Asad Patanwala was awarded the American Society of Health-System Pharmacists Association’s Research and Education Pharmacy Practice and Research Literature Award for the article “A Prospective, Multicenter Study of Pharmacist Activities Resulting in Medication Error Interception in the Emergency Department.”

• Mazda Shirazi has been inducted as a fellow of the American College of Medical Toxicology.

• Georg Wondrak was elected to lead the American Society for Photobiology. He will serve as ASP president-elect for 2014–2016, and as ASP president for 2016–2018.

Grants

• Eli Chapman and Donna Zhang, NIH, $1.7 million, “Stress response, p97, and Nrf2 in arsenic-medicated toxicity.”

• Jeannie K. Lee, NIH, $1.48 million, “Chronic Disease Health Beliefs, Medication Adherence, and Health Literacy.”

Promotions

• Jennifer R. Martin promoted to associate librarian, information services • Catharine Smith promoted to associate professor with tenure in the Department of Pharmacology and Toxicology • Daekyu Sun promoted to associate professor with tenure in the Department of Pharmacology and Toxicology

The University of Findlay Appointments/Elections

• Debra Parker has been appointed to serve as interim dean.

2014 Issue 3

The University of Georgia Appointments/Elections

• Dexi Liu, appointed deputy editor of Molecular Therapy • Susan C. Fagan appointed to EUREKA study section (NINDS): June 5, 2014; and NSD-A Study Section (NINDS).

Awards

• Mike J. Fulford and Lindsey Welch, Winners of this year’s AACP Award for Excellence in Assessment • Jeremy Headrick, Staff Service Award (Five Years) • Kalen B. Manasco received the Spirit of PPAG Award at the annual Pediatric Pharmacy Advocacy Group meeting.

• Michael Neville received the Teacher of the Year award for 2014.

• Lynn Parham, Staff Service Award (Five Years) • Jeanne Prine, Staff Service Award (20 Years) • Jeff Sanford received the Walter Barnard Hill Distinguished Public Service Fellow Award.

• Ken Schroder, Staff Service Award (25 Years) • Kimberly Smith, Staff Service Award (Ten Years) • Joy Wilson was named the 2013 Employee of the Year at The University of Georgia College of Pharmacy.

Grants

• Aaron Beedle, awarded $389,910 from the National Institutes of Health for study of elucidating muscle regeneration defects in fukutin ko mice.

• David Chu received First Poster presentation award for the presentation of “A Convergent Synthesis of AntiHBV Agent, FMCA and Its Prodrug (FMCAP).”

• Brian Cummings received $9,893 from Auburn University for study of secretory phospholipases SPLA2 and their receptors for delivering nanoparticles.

• Azza El-Remessy received $308,700 from National Institutes of Health for continuing study of molecular mechanisms of diabetic retinopathy.

• Susan C. Fagan received $17,280 and $25,200 from the U.S. Department of Veterans Affairs for mechanisms and consequences of hypertension after a stroke.

faculty news • Rajgopal Govindarajan received $74,250 from National Institutes of Health for study elucidating mitochrondrial pathomechanisms of ENT3 disorders in ENT3 KO mice.

• Shelley Hooks Received $44,000 from the National Multiple Sclerosis Society for study of anti-inflammatory mechanisms of microglial regulator of G-protein signaling 10 (RGS10).

• Scott Pegan received $251,056 from National Institutes of Health for study of origin of the innate immunity suppression caused by nairovirus protease activity.

• Lakshman Segar received $25,713 from National Institutes of Health for study of vascular phenotypic regulation by growth factors, insulin and Glucose.

• Somanath Shenoy received $308,700 from the National Institutes of Health for study of protein kinase B (AKT)mediated pathway regulating endothelial-barrier function.

• Jason Zastre received $171,630 from the National Institutes of Health for study of adaptive regulation of vitamin B1 transport.

The University of Iowa Appointments/Elections

• Jonathan Doorn was selected as an Obermann Center Fellow in Residence for the fall 2014 semester.

• Diana Karkow was appointed as pharmaceutical fellow with the College of Pharmacy and University of Iowa Hospitals and Clinics in the Department of Infectious Disease.

• Rob Kerns was selected as member of the 2014–2015 Committee on Institutional Cooperation Academic Leadership Program Fellows.

• Kate M. Oltrogge was selected as chairelect of the American Burn Associations Pharmacy Special Interest Group.

• Matthew Osterhaus, president, American Pharmacists Association • John Swegle was installed as president of the Iowa Pharmacy Association for the 2014-2015 term.

• Sara Wiedenfeld, clinical assistant professor

Awards

• Barry Carter, 2014 Roland T. Lakey Lecture Award

Grants

• Barry L. Carter received a $10,112,371 one-year award from the U.S. Department of Health and Human Services and the National Institutes of Health for “MEDication Focused Outpatient Care for Underutilization of Secondary Prevention.”

• Jon Doorn received the CHEEC Seed Grant for $29,990 for “Toxicity of Organophospate and Carbamate Pesticides for Neuronal and Non-Neuronal Cells.”

• William R. Doucette received $174,976 from the Iowa Department of Public Health for “Extending Provider-Pharmacist Team Management of Hypertension in the Community Year 2.”

• Colin Higgins, American Society for Pharmacology and Therapeutics Washington Fellow • Barry Carter, National Institutes of Health/National Heart, Lung, and Blood Institute grant for his work, “MEDication Focused Outpatient Care for Underutilization of Secondary Prevention.”

• Robert Kerns received a $22,650 one-year grant from the University of Medicine & Dentistry of New Jersey for “Using Click Chemistry to Identify Potential Drug Targets in Plasmodium.”

• Lee Kirsch received a new $169,995 two-year award from NIPTE for “Particle Size Distribution Equivalency using Novel Statistical Comparator and PBPK Input Model.” He was also awarded a $169,995 two-year grant from the National Institute for Pharmaceutical Technology and Education for “Particle Size Distribution Equivalency using Novel Statistical Comparator and PBPK Input Models.”

• Stevie R. Veach was awarded a $2,500 grant from the National Association of Chain Drug Stores Foundation for “Transition of Care for Behavioral Health Patients Between a Hospital and Community Pharmacy.”

• Aliasger Salem was awarded $9,900 from Iowa State University for “Developing a CPTEG: CPH nanoparticle cancer vaccine formulation that is co-loaded with tumor specific antigens and TLP9 agonist CpG ODN.” He also received the Environmental Health Sciences Research Center Seed Grant for $6,000.

• Aliasger Salem and Balaji Narasimhan have been awarded pilot grant funding for Developing a CPTEG:CPH nanoparticle cancer vaccine formulation that is co-loaded with tumor specific antigens and TLR9 agonist CpG ODN from the ISU Nanovaccine Institute.

• Mary Schroeder was awarded $125,496 from the University of South Carolina for Understanding Treatment Effect Estimates When Treatment Effects Are Heterogeneous For More Than One Outcome.

Promotions

• Kevin Bebout, adjunct assistant professor • Jennifer Fiegel, associate professor • Kevin Gamble, adjunct associate professor • Kelly Hoenig, adjunct associate professor • Jeffrey C. Reist, clinical associate professor • David L. Roman, associate professor • Aliasger Salem, professor

The University of Mississippi

Appointments/Elections

• David A. Colby, associate professor of medicinal chemistry and research associate professor, Research Institute of Pharmaceutical Sciences • Stephen J. Cutler, chair of the Department of BioMolecular Sciences • Whitney Harris, clinical instructor of pharmacy practice • Meagen M. Rosenthal, assistant professor of pharmacy administration • Lindsay Brett Smith, clinical instructor of pharmacy practice • Lori Ward, assistant professor of pharmacy administration

Grants

• Benjamin Banahan, principal investigator, Kyle Null, co-principal investigator, Patrick Pace, co-principal investigator, Mississippi Division of Medicaid/U.S. Department of Health and Human Services, $1,890,936, Mississippi Medicaid Retrospective Drug Utilization Review, DUR Board Facilitation, Analytical Support, and 2nd Level Appeals for Prior Authorization

ACADEMIC PHARMACY NOW 

2014 Issue 3

41

faculty news • Tracy Brooks, principal investigator.

Source of Award: U.S. Army Medical Research Acquisition Activity. Amount: $333,878. Title: Novel Molecular Targets for kRAS Downregulation: Promoter G-Quadruplexes.

• Amar Chittiboyina, University of Mississippi Medical Center/National Institutes of Health, $37,971, Roles of Hyaluronic Acid in Cancer Stem Cell Niche • Mahmoud ElSohly, principal investigator, Ikhlas Khan, co-principal investigator, National Institute of Drug Abuse, $1,248,501, Production, Analysis and Distribution of Cannabis, Marijuana Cigarettes and Related Materials • Mark Hamann, principal investigator.

Source of Award: Kraft Foods Group, Inc. Amount: $99,120. Title: New Natural Products as Replacements for Water Soluble Yellow Food Dyes. He also received $50,954 from Biosertia Pharmaceuticals for “Screening and Bioassay Guided Isolation and NMR Studies of Marine Products.”

• Melissa Jacob, Florida Agricultural and Mechanical University/National Institutes of Health, $13,660, Development of New Agents Against Cryptococcal Infections • Ikhlas Khan, Larry Walker, investigators. Source of Award: U.S. Department of Agriculture. Amount: $450,850.

Title: Discovery and Development of Natural Product-Based Insect Management Compounds for Medical, Veterinary and Urban Concern.

• S. Narasimha Murthy, Ligand Pharmaceuticals Incorporated, $40,597, Dermal Delivery of Therapeutic Agents using Cyclodextrin Derivatives • David Pasco, Colin Jackson, Nirmal Pugh, investigators. Source of Award: National Institutes of Health. Amount: $295,920. Title: Immune Enhancing Echinacea Bacterial Endophytes.

• Michael A. Repka, principal investigator, Soumyajit Majumdar, co-principal investigator, Catalent Pharma Solutions, LLC, $70,000, Twin Screw Granulation and the Application of QbD and PAT • Leigh Ann Ross, Lauren S. Bloodworth, investigators. Source of Award: Mississippi Public Health Institute/Duke University/U.S. Department of Health

42

ACADEMIC PHARMACY NOW 

and Human Services, Center for Medicare and Medicaid Services. Amount: $40,736. Title: Southern United States Diabetes Coalition.

• Leigh Ann Ross, Lauren S. Bloodworth, investigators. Source of Award: University of Mississippi Medical Center.

Amount: $187,922. Title: Mississippi Diabetes Health Care Network Initiative.

• Leigh Ann Ross, principal investigator, Lauren S. Bloodworth, co-principal investigator. Source of Award: National Association of Chain Drug Stores Foundation. Amount: $600,000. Title: Pharmacist Linkage in Care Transitions: From Academic Medical Center to Community.

• Leigh Ann Ross, principal investigator, Lauren S. Bloodworth, co-principal investigator. Source of Award: Mississippi State Department of Health/Centers for Disease Control and Prevention.

Amount: $68,186. Title: Quality and Medication Adherence Educational Workshops.

• Leigh Ann Ross, principal investigator, Lauren S. Bloodworth, co-principal investigator, Mississippi Public Health Institute/Duke University/U.S. Dept. of Health and Human Services, Centers for Medicare and Medicaid Services, $29,313, Southern United States Diabetes Coalition • Leigh Ann Ross, principal investigator, Lauren S. Bloodworth, co-principal investigator, Mississippi State Department of Health/Centers for Disease Control and Prevention, $406,978, Pharmacy Cardiovascular Risk Reduction Project • Larry Walker, principal investigator, Babu Tekwani, co-principal investigator, Dhammika Nanayakkara, co-principal investigator, U.S. Army Medical Research Acquisition Activity, $1,383,151, Development of Safer Drugs for Treatment of Malaria in U.S. Troops, Civilian Personnel and Travelers • Jordan Zjawiony, The University of North Carolina at Chapel Hill/National Institute on Drug Abuse, $57,298, Diterpenes as Selective Kappa Opioid Receptor Agents

Promotions

• Erin R. Holmes, associate professor of pharmacy administration

2014 Issue 3

• Katie S. McClendon; assistant dean for student services, director of student affairs for pharmacy practice, and clinical associate professor of pharmacy practice

Retirements

• Anthony J. Verlangieri, professor of pharmacology and research professor, Research Institute of Pharmaceutical Sciences

The University of Montana Appointments/Elections

• Reed Humphrey has been appointed new dean of the University of Montana Skaggs School of Pharmacy.

Retirements

• David Forbes retired as dean after 26 years of service to the school.

The University of Tennessee Appointments/Elections

• Bradley A. Boucher has been appointed the new associate dean for strategic initiatives and operations.

• Theodore J. Cory was appointed assistant professor in the Department of Clinical Pharmacy’s Division of Clinical and Experimental Therapeutics.

• Kenneth C. Hohmeier, assistant professor of clinical pharmacy • Amanda M. Howard-Thompson was appointed by the American Pharmacists Association to the editorial advisory board of Pharmacy Today.

• Santosh Kumar, assistant professor of pharmaceutical sciences • Emma Tillman was appointed assistant professor in the Department of Clinical Pharmacy, Division of Clinical and Experimental Therapeutics.

Awards

• Marie A. Chisholm-Burns received the 2014 American Pharmacists Association Research Achievement Award.

• Catherine M. Crill, American Society for Parenteral and Enteral Nutrition Distinguished Nutrition Support Pharmacist Service Award • Kenneth C. Hohmeier, National Association of Chain Drug Stores Faculty Scholar • G. Christopher Wood was selected as a preceptor for the American Society of Health-System Pharmacy critical care traineeship program.

faculty news Grants

• Michelle Z. Farland received a grant in the amount of $3,011 from the Physicians Medical Education and Research Foundation.

• S. Casey Laizure, and Robert Parker received a $150,000 grant from the National Institute on Drug Abuse to study how rapidly caffeine gets into the body after consuming an energy drink or inhaling a caffeine powder.

• Bernd Meibohm received a shared instrumentation grant in the amount of $315,651 from the National Institutes of Health.

Promotions

• Wei Li, promoted to full professor of pharmaceutical sciences, with tenure

The University of Toledo Appointments/Elections

• Amanda C. Bryant-Friedrich, director of international pharmaceutical sciences graduate student recruitment and retention • Ezdihar Hassoun, chair, Department of Pharmacology • Monica G. Holiday-Goodman, assistant dean for diversity and community engagement • Surya Nauli, vice chair, Department of Pharmacology

Awards

• Mariann Churchwell, Teacher of the Year • Caren Steinmiller, Professor of the Year

Grants

• Salah-uddin Ahmed, NIH/NIAMS, $318,325, Regulation of IL-6 mediated inflammation and tissue destruction

by EGCG. He also received $220,819 from Roche/Genentech for “Efficacy of Tocilizumab in IL-6-induced Dyslipidemia.”

• Kenneth S. Alexander, Waters Instrumentation, $15,000 • Sai HanumanSagar Boddu, $9,980, International Academy of Compounding Pharmacists, Preparation and Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic acid for the Transdermal Delivery of Ketoprofen • Amanda C. Bryant-Friedrich, NSF, $300,000 Surya Nauli, NIH/NIDDK, $299,910, The Roles of Primary Cilia in Cardiovascular System

• Michelle Mangan, American Association of Diabetes Educators Education and Research Foundation, $15,000, Continuous Quality Improvement Grant, Motivational Interviewing in Diabetes Education and Adherence • Julie Murphy, Cardinal Health Foundation, $31,500, Cardiac Patient Medication Transition Pilot Program • Sharrel Pinto, Omnicell, $30,000, Improving Medication Adherence through the use of a compliance packaging system. She also received 20,000 from the Joe and Judith Conda Foundation for “Research and outcomes associated with Medication Therapy Management” and $10,000 from ProMedica and the Jobst Vascular Institute for “Assessing outcomes of patients receiving treatment at the Jobst Vascular Institute.”

• Mary Powers, The Kroger Company, $61,000, The University of Toledo Community Pharmacy Residency Program • Youssef Sari, NIH-NIAAA, $220,819, The Role of GLT1 in the Modulation of Alcohol-Drinking Behavior in P Rats • Michelle L. Serres, American Association of Diabetes Educators, $20,000, Diabetes Education Continuous Quality Improvement Grant • Varun Vaidya, Bristol-Myers Squibb, $11,107, Impact of cardiovascular comorbidities on patients with type diabetes: Proposed strategy for systematic review

Promotions

• Gabriella Baki, assistant professor of pharmacy practice • Diane M. Cappelletty, interim vice chair of the Department of Pharmacy Practice • Vincent F. Mauro, interim chair of the Department of Pharmacy Practice • Richard Montgomery, research assistant professor • Jerry Nesamony, associate professor of pharmaceutics • Sharrel Pinto, vice chair for health outcomes and socioeconomic sciences • Youssef Sari, associate professor of pharmacology • Hermann von Grafenstein, vice chair of the Department of Medicinal and Biological Chemistry

• Frederick E. Williams, vice chair of the Department of Pharmacology

Touro University California Appointments/Elections

• Rae Matsumoto has been appointed dean.

Grants

• The Touro University California College of Pharmacy received a $150,000 grant from the Joseph & Vera Long Foundation to increase research and classroom space on its campus.

University at Buffalo, The State University of New York Appointments/Elections

• Michelle Amsler, pharmacy resident, Pharmacy Practice • Jessica Beyer, pharmacy resident, Pharmacy Practice • Lisa Garza, pharmacy resident, Pharmacy Practice • Holly Hamilton, pharmacy resident, Pharmacy Practice • Ryan Lindenau, pharmacy resident, Pharmacy Practice • Jeffrey Lombardo, research assistant professor, Pharmacy Practice • Kimberly Mulcahy, pharmacy resident, Pharmacy Practice • Alyssa M. Pignato, pharmacy resident, Pharmacy Practice

Awards

• Joshua Sawyer, awarded the 2014 Rho Chi Excellence in Teaching Award • Carolyn A. Hempel, awarded the 2014 Rho Chi Outstanding Alumni Award • Karl Fiebelkorn, awarded the 2014 Bowl of Hygeia Award. In addition, Rochester Drug Cooperative established The Professor Karl D. Fiebelkorn Award in Independent Pharmacy to support UB Pharm.D. students interested in independent community practice.

• Ashley Woodruff, awarded the 2013 Educator/Preceptor of the Year New York State Chapter of the American College of Clinical Pharmacy

Grants

• Javier G. Blanco, awarded a grant from Eunice Kennedy Shriver National Institute of Child Health and Human Development for Characterization of

ACADEMIC PHARMACY NOW 

2014 Issue 3

43

faculty news Cardiac Mitochondrial DNA in Donors with Down Syndrome.

• Alice Ceacareanu, awarded $530,000 from the New York State Health Workforce Retraining Initiative • Eugene D. Morse was awarded, as co-investigator, a SUNY 4E Planning Grant to support a two-day forum for developing technology innovation and promoting regional and global collaboration.

• Brian Tsuji, awarded a $4.4M five-year National Institutes of Health NIAID R01 grant for “Novel PK/PD Strategies for Polymyxin Combinations against Gram-negative Superbugs.” Co-investigators include Juergen Bulitta and Alan Forrest.

Promotions

• Kathleen M. Boje, associate dean for academic affairs • Karl Fiebelkorn, senior associate dean for student, professional, and community affairs • Marilyn E. Morris, distinguished professor, pharmaceutical sciences; vice chair, pharmaceutical sciences • Kathleen Tornatore-Morse, professor, pharmacy practice

University of California, San Diego • James H. McKerrow was selected to serve as the second dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences.

University of California, San Francisco Appointments/Elections

• Timothy Cutler now holds the Divine Family Endowed Chair in Clinical Pharmacy • Lisa Kroon now holds the Thomas A. Oliver Endowed Chair in Clinical Pharmacy.

• James Fraser was named a 2014 Searle Scholar. James’ laboratory will be awarded $300,000 in funding over the next three years to support his research toward precisely describing how protein molecules change shape to carry out their essential functions in our bodies.

44

ACADEMIC PHARMACY NOW 

• Sourav Bandyopadhyay received a $354,938 grant from the Japanese pharmaceutical company Daiichi-Sankyo as part of a larger Daiichi-UCSF alliance to find genetic markers identifying which cancer patients would best respond to Daiichi drugs now under development.

• Zev Gartner received a 2013 National Institutes of Health Director’s New Innovator Award. The award will provide his lab with up to $1.5 million in research funding over the next five years.

• Francis Szoka received a two-year $201,235 grant from the National Cancer Institute.

• James Wells has received a two-year $220,814 grant from the National Institute of Allergy and Infectious Diseases.

University of Colorado Appointments/Elections

• Laura M. Borgelt and Ty Kiser were recently recognized by the University of Colorado with the Chancellor’s Teaching Recognition Award and the President’s Excellence in Teaching Award.

University of Florida Appointments/Elections

Appointments/Elections

Awards

Grants

• Diane E. Beck was appointed associate dean for curriculum and accreditation.

• Oliver Grundmann received a threeyear appointment to the International Advisory Board of the National Science Teachers Association.

• Denise M. Klinker has been appointed clinical assistant professor of pharmacotherapy and translational research and director of the Office of Experiential Programs.

• Ian Tebbett was appointed associate dean for entrepreneurial programs and IT. • Karen Whalen has been appointed assistant dean for clinical education, has been promoted to clinical professor of pharmacotherapy and translational research.

Awards

• Julie A. Johnson received the University of Florida Research Foundation Professorship 2013–2015.

• Larry Lesko was recognized as the first-ever recipient of the Distinction in Biomarker Research Award by the

2014 Issue 3

American Association of Pharmaceutical Scientists.

• Robin M. Li was named 2014 Teacher of the Year.

• Kristin W. Weitzel received the 2014 American Pharmacist Association, Academy of Pharmacy Practice and Management Distinguished Achievement Award.

• Almut G. Winterstein was one of three fellows named worldwide for 2013– 2014, as a Fellow of the International Society of Pharmacoepidemiology.

Grants

• Guohua An received a $43,800 pilot award from UF CTSI to support her clinical trial project, “Explore the Synergy of Combination TKI Therapy – A Pilot Study to Evaluate the Effect of Imatinib on Dasatinib Pharmacokinetics in Healthy Volunteers.”

• Rhonda Cooper-DeHoff received a $20,240 pilot study from the University of Florida Southeast Center for Integrated Metabolomics and UF Clinical and Translational Science Institute, “A targeted pharmacometabolomic investigation of the acylcarnitine pathway and incident impaired fasting glucose.”

• Anna Hall received a $50,000 Research Starter Grant from the Pharmaceutical Research and Manufacturers of America Foundation to study and improve medication adherence.

• Robert Huigens received an $84,000 grant from the UF 2014 Research Opportunity Seed Fund for “Development of Potent 2,4‐Dibromophenazine Antibacterial Antibiofilm Agents.”

• Hendrik Luesch received a two-year, $400,000 award from the Florida Department of Health through the Bankhead Coley Cancer Research Program to continue his work, “Chemistry and Biology of Apratoxins” in cancer drug discovery and development.

• Charles Peloquin and Guohau An received a $342,000, three-year award from the Critical Path Institute for “Pharmacokinetics and pharmacodynamics of tuberculosis drugs in patients with active disease” in a collaborative effort of TB treatment centers in Texas and Florida.

• Karen R. Sando was awarded a 2014 Faculty Enhancement Opportunity Award of $18,703.

faculty news • Almut G. Winterstein received a two year $510,788 research contract from the Center for Medicare & Medicaid Services and Agency for Health Care Administration to support three key studies: Attention Deficit Disorder and Attention Deficit Disorder with Hyperactivity Treatment Patterns in Adult Medicaid Beneficiaries; Psychotropic Polypharmacy in Florida Medicaid; Age-related Effects of Respiratory Syncytial Virus (RSV) Risk in Children with Chronic Lung Disease.

Promotions

• Oliver Grundmann has been promoted to clinical associate professor of medicinal chemistry.

Retirements

• David Brushwood, professor of pharmaceutical outcomes and policy • Carole Kimberlin, professor of pharmaceutical outcomes and policy

University of Illinois at Chicago Appointments/Elections

• Scott Benken, clinical assistant professor, Department of Pharmacy Practice • Shuba Bhat, clinical assistant professor, Department of Pharmacy Practice • Michelle L. Bryson, clinical assistant professor, Department of Pharmacy Practice • Thomas D. Chiampas, clinical assistant professor, Department of Pharmacy Practice • Leena Deshpande, clinical assistant professor, Department of Pharmacy Practice • Julio Duarte, assistant professor, Department of Pharmacy Practice • Amanda L. Eades, clinical assistant professor, Department of Pharmacy Practice • Meghan E. Fleischman, clinical assistant professor, Department of Pharmacy Practice • Alan Gross, clinical assistant professor, Department of Pharmacy Practice • Jin Han, clinical assistant professor, Department of Pharmacy Practice • Jason Hickok, research assistant professor & assistant director, UICentre– UIC’s Drug Discovery Initiative

• Nina Hyuhn, clinical assistant professor, Department of Pharmacy Practice • Archana Jhawar, assistant professor, Department of Pharmacy Practice • Zahra Kassamali, clinical assistant professor, Department of Pharmacy Practice • Lisa Marie Kumor, clinical assistant professor, Department of Pharmacy Practice • Hyunwoo Lee, assistant professor, Department of Biopharmaceutical Sciences • Alice Memenway, clinical assistant professor, Department of Pharmacy Practice • Terry W. Moore, assistant professor, Department of Medicinal Chemistry • Christina Rash, clinical assistant professor, Department of Pharmacy Practice • Christina Pearl Stier, clinical assistant professor, Department of Pharmacy Practice • Scott M. Wirth, clinical assistant professor, Department of Pharmacy Practice

Awards

• Judy L. Bolton was named the 2013 UIC Woman of the Year by the UIC Chancellors Committee on the Status of Women.

• Joanna Burdette is a recipient of the 2013 UIC Researcher of the Year Rising Star award.

• Alexander Mankin has been named as a 2014 Fellow for the American Academy of Microbiology.

Grants

• Mike Federle and Terry W. Moore received Chicago Biomedical Consortium HTS awards of $20,000 each for their projects Signal Jamming of Bacterial Communication: An HTS Approach and Inhibition of Cystationine G Lysase as a Therapeutic Approach for Relief of Sleep Disorder Breathing, respectively.

• Seungpyo Hong is a subcontract PI on Alex’s Lemonade Stand award for project Development of microRNANanoparticles to Treat Childhood Acute Leukemia Carrying MLL Rearrangements.

• Michael E. Johnson and his University of Chicago collaborator, Robert

Daum, received the Chicago Biomedical Consortium Catalyst Award for a project A Novel Antimicrobial Strategy Against Methicillin-Resistant S Aureus (MRSA).

• Alan Kozikowski received a four year R01 grant for $798,394 from the NIH National Institute of Mental Health for project Optimizing Lead 5-HT2C Ligands for use in the Treatment of Schizophrenia.

• Todd Lee, Harvard Pilgrim Health Care, “A Protocol Assessment of Selected Medications and Death, With Linkage of Mini-Sentinel Distributed D” • Todd Lee, Harvard Pilgrim Health Care, “Analytical Methods to Access the Robustness of Drug Safety Monitoring” • Todd Lee, University of Arizona, “The Cost Effectiveness Of School Based Supervised Asthma Therapy” • Andrew Merker, Bristol-Meyers Squibb, “Evaluation of Safety and Efficacy of First-Line Antiretroviral and Single Tablet Regimens (STR)” • Terry W. Moore received a $10,000 award from AACP for project Tucked Stapled Peptides for Estrogen Receptor/ Coactivator Interaction.

• Brian Murphy and Scott Franzblau each received an award from the Department of Defense for their project Development of Diazaquinomycin Class Antibiotics for the Treatment of Drug-Resistant TB Infections, with $577,300 awarded to each investigator.

• Hayat Onyuksel received $150,000 from the Penny Severns Breast, Cervical and Ovarian Cancer Research Fund for project Phase I Study of Nanomedicine, Paclitaxel Micelle Targeting VIP Receptor for Therapy of Solid Tumors.

• Pavel Petukhov received an R21 grant for $222,119 from NIH NIAID. Focus of this project is Discovery of Novel Anti-HBV Compounds Targeting Host Factors.

• Alan Pickard, ARIAD Pharmaceuticals, “BCR-ABL1 Mutations Conferring Treatment Resistance to Tyrosine Kinase Inhibitors” • Keith Rodvold, Theravance, “Cross-Reactivity of Telavancin with Vancomycin Immunoassays” • Monsheel Sodhi, Jeffrey Bishop and Bernard Santarsiero received funding

ACADEMIC PHARMACY NOW 

2014 Issue 3

45

faculty news for their project Launching a UIC Brain Tissue Repository for Investigations of Psychiatric Disorders.

• Jessica Tilton, American College of Clinical Pharmacy, “Medication Therapy Management Clinic: The Impact on Clinical Parameters and Resource Utilization” • Debra Tonetti received the Cancer Center 2014 Pilot Award for her project Establishment of a relevant breast cancer pre-clinical model: patient-derived xenografts.

• Daniel Touchette, Sunovion Pharmaceuticals, “Beliefs and Attitudes Towards Antipsychotic Use in Patients with Schizophrenia and Bipolar Disorder” • Richard van Breemen received an R01 grant for $259,556 from NIH NCCAM for project, “Rapid Identification of Active Agents and Metabolomics of Botanical Supplements.”

Promotions

• Jaki Birgit, research associate professor, Department of Medicinal Chemistry • Joanna Burdette, associate professor, Department of Medicinal Chemistry • Vicki Groo, research associate professor, Department of Pharmacy Practice • Dan Touchette, Takeda Professor of Medication Adherence, Department of Pharmacy Systems, Outcomes, and Policy • Douglas Thomas, associate professor, Department of Medicinal Chemistry • Zaijie (Jim) Wang, associate professor, Department of Biopharmaceutical Sciences,

Retirements

• Adam Negrusz, associate professor, Department of Forensic Science

University of Maryland Appointments/Elections

• Nicole J. Brandt has been named the 2015–2016 president-elect of the American Society of Consultant Pharmacists.

• Bethany DiPaula has been appointed to the Maryland State Overdose Advisory Councils Pharmacists Prescribing Naloxene Workgroup and has been appointed to the American Society of Health-System Pharmacists’ Section Advisory Group on Preceptor Skill Development.

46

ACADEMIC PHARMACY NOW 

• Natalie D. Eddington has been named chair of the AACP Research and Graduate Affairs Standing Committee.

• C. Daniel Mullins has been named chair of the Schools Department of Pharmaceutical Health Services Research.

• Deanna Tran has been reappointed to the American Pharmacists Association’s Academy of Pharmacy Practice and Management Awards Standing Committee and has been named chair of American Pharmacists Association’s New Practitioner Network Communications and Networking Standing Committee.

Awards

• Richard N. Dalby and Lisa Lebovitz were co-recipients of the AACP 2014 Excellence in Assessment Award.

• Stephen Hoag and James Polli were awarded a U.S. patent for a method to evade and detect counterfeit drug products.

• Ahmed Ibrahim received second place in the Software Shootout competition at the 17th International Diffuse Reflectance Conference.

• C. Daniel Mullins has been named a corecipient of the University of Maryland, Baltimore’s Researcher of the Year Award.

• Magaly Rodriguez de Bittner has been named a Maryland Daily Record 2014 Innovator of the Year.

Grants

• Andrew Coop received a nine-month $100,000 grant from the Maryland Technology Development Corporation for UMB425: A Unique Opioid Analgesic with Reduced Tolerance.

• Bethany DiPaula received a one-year $80,981 contract from the Howard County Health Department.

• Maureen Kane received a five-year $863,438 contract from the University of Kansas Center for Research for Molecular Determinants of Retinoid Metabolism in Embryonic Tissues.

• Linda Simoni-Wastila received a twoyear $207,178 contract from Novartis Pharmaceuticals Corp for Novartis HEOR Fellowship.

• Patrick L. Wintrode received a two-year $200,000 grant from the Alpha-1 Foundation for Modeling Misfolded Z Alpha 1-antitrypsis for in silico Drug Design.

2014 Issue 3

• Fengtian Xue received a one-year $100,000 grant from the Leukemia Research Foundation for “Small Molecule BCL6 Inhibitors for Diffuse Large B-cell Lymphoma.”

University of Maryland Eastern Shore Appointments/Elections

• Cynthia J. Boyle has been appointed interim dean of the School of Pharmacy and Health Professions at the University of Maryland Eastern Shore.

Awards

• Hoai-An Truong, Maryland Pharmacists Association 2014 Innovative Practice Award

Grants

• Hoai-An Truong, 2014 Delmarva Foundation for Medical Care Quality Improvement Organization contract, $25,000, PI for the Development and Implementation of a Medication Reconciliation Community Toolkit

University of Michigan Appointments/Elections

• James T. Dalton was named the new dean of the University of Michigan College of Pharmacy.

University of Minnesota Appointments/Elections

• Derek Jennings has accepted an assistant professor position in the Department of Pharmacy Practice and Pharmaceutical Sciences.

• Meg Little has accepted an assistant professor position in the Department of Pharmacy Practice and Pharmaceutical Sciences.

Awards

• Oscar W. Garza received an AACP New Investigator Award of $10,000 for his project, Development of a Community Pharmacy Social Capital Assessment Tool.

• Gunda I. Georg received $8.3M (over five years) from the National Institute of Child Health and Human Development to design, synthesize and evaluate non-hormonal contraceptives for men and women.

• Dan Harki received a $23,000 Engebretson/Bighley Drug Design & Development Grant for his project,

faculty news Discovery of APOBEC3B Small Molecule Inhibitors.

• Derek Jennings and Michelle JohnsonJennings received a $50,000 award from the NIH National Institute of Diabetes and Digestive and Kidney Diseases for their project, Reducing Obesity in Tribal Communities: Identifying Needs Through Photovoice.

• Ling Li received a $23,000 Engebretson/Bighley Drug Design & Development Grant for her project, Therapeutic Potential of a Novel Neuroprotective Agent for Alzheimers Disease.

• Amy L. Pittenger received a $100,000 extension grant from the U.S. Department of Health and Human Services to develop and implement interprofessional education preceptor development using a palliative care clinical context.

• Jon C. Schommer is part of a project team for the Centers for Disease Control and Prevention project, Improving HIV Prevention and Treatment Outcomes among HIV-Infected Persons by Integrating Community Pharmacists and Clinical Sites into a Model of Patient-Centered HIV Care.

This is a three-year project with a budget of $2,398,000. He also received a $17,273 award from Data Intelligence Consultants for the project, Data IQ Traineeship.

• Todd D. Sorensen and Sarah M. Westberg received Leading Edge Advanced Practice Topics funding from Centers for Medicare & Medicaid Services for their project Improving Transitions of Care through Comprehensive Medication Therapy Management. This is a partnership with Minnesota Hospital Association.

University of New England Promotions

• John L. Redwanski Jr. promoted to clinical associate professor.

University of North Carolina at Chapel Hill Appointments/Elections

• Angela Kashuba has been named to the National Institutes of Health Advisory Committee on Research on Women’s Health.

• Betsy Shilliday has been named a 2014 fellow by the American Society of Health-System Pharmacists.

• Betsy L. Sleath has been named as the new director of the program on Child Health Services at the Cecil G. Sheps Center for Health Services Research at the University of North Carolina at Chapel Hill.

Awards

• Jena Ivey Burkhart has been awarded the 2014 Dale Jones Memorial Award for Excellence in Geriatrics from the North Carolina Association of Pharmacists.

Grants

• Stacy C. Bailey, Merck Sharp and Dohme, $23,366, A Mixed Methods Approach to the Development and Testing of the Measure of Drug SelfManagement (Meds), an Assessment for Use in Clinical Settings among English- and Spanish-Speaking Patients with Hypertension and Diabetes. She also received $22,213 from Northwestern University for Tools for Optimizing Medication Safety (TOP-MEDS).

• Julie Dumond, National Institute of Allergy and Infectious Diseases, $109,239, Optimizing Antiretroviral Use in Aging: Pharmacokinetics, Response, and Toxicity • Stephen Frye, NIH National Institute of General Medical Sciences, $281,200, Discovery of Chemical Probes for Methyl-Lysine Readers • Leaf Huang, National Cancer Institute, $264,611, Novel Nanoparticles for siRNA Delivery William Janzen, Duke University, $23,387, Duke-CICBDD Services Agreement • William Janzen, Washington University in Saint Louis, $61,618, Subcontract from Washington University • Michael Jarstfer, National Institute on Aging, $31,736, The Connection between Reactive Oxygen Species and Telomeres in Cardiovascular Disease • Rudolph Juliano, National Cancer Institute, $276,390, Intracellular Trafficking of Antisense and siRNA Oligonucleotides in Cancer Cells • Angela Kashuba, NIH National Institute of Allergy and Infectious Diseases, $808,479, Multispecies Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs

• Sam Lai, Pharmaceutical Research and Manufacturers of America Foundation, $20,000, Engineering Immune-Inert for Lymphatic Drug Delivery • David Lawrence, National Cancer Institute, $259,318, Synthetic Regulators of Tyrosine Protein Kinase • Andrew Lee received $30,110 from the National Institute of General Medicine Science and $270,986 from the National Institute of General Medicine Science for “Intra- and Intermolecular Dynamics of Dihydrofolate Reductase.”

• Jian Liu, Rensselaer Polytechnic Institute, $93,206, Synthetic Heparan Sulfate: Probing Biosynthesis to Prepare Defined Drugs Philip Smith, Eli Lilly and Company, $30,414, Targeted Quantitative Proteomics Analysis of OATP and Other Transporters in Humanize Mice • Rihe Liu, Rutgers, the State University of New Jersey, $30,260, Function and Regulation of Metacaspases in Plant Cell Death. He also received $275, 180 from the National Cancer Institute for “Novel Single Domain Antibodies with Multivalency and Multispecificity.”

• Dhiren Thakker, NIH National Cancer Institute, $68,400, Transporters in Metformin Treatment of Endometrial Hyperplasia • Alexander Tropsha, Office of Naval Research, $100,000, Materials Informatics: Expansion of the Aflowlib Database of Electronic Properties of Materials and the Development of Novel Materials Fingerprints for Efficient Database Mining and QSPR Modeling • Tim Wiltshire, University of Pennsylvania, $25,000, Personalization of Therapeutic Efficacy and Risk • Xiao Xiao, National Institute of Diabetes, Digestive and Kidney Diseases, $329,300, Muscle as a Platform for Type 2 Diabetes Treatment by Gene Delivery.

He also received $329,176 from the NIH National Institute of Neurological Disorders and Stroke for “Gene Delivery to Muscle and Nerve for Laminin-Alpha2Deficient MD (MDC1A).”

University of Pittsburgh Appointments/Elections

• Lucas Berenbrok was named assistant professor of pharmacy and therapeutics.

ACADEMIC PHARMACY NOW 

2014 Issue 3

47

faculty news • Melissa A. Somma McGivney, American Pharmacists Association, elected fellow • Samuel M. Poloyac, American College Of Critical Care Medicine, elected fellow • Jennifer Pruskowski, assistant professor of pharmacy and therapeutics • Bridget Walker was named director of the Pharmacy Business Administration program.

• Da Yang, assistant professor of pharmaceutical sciences

Awards

• Philip Empey, Society Of Critical Care Medicine, New Investigator Award • Sandra L. Kane-Gill, American College Of Clinical Pharmacology, Critical Care PRN Achievement Award • Patricia Kroboth, American College Of Clinical Pharmacology, Bristol-Myers Squibb Mentorship in Clinical Pharmacology Award • Karen S. Pater, Pennsylvania Pharmacists Association, Preceptor of the Year Award • Samuel M. Poloyac, University Of Pittsburgh, Chancellors Distinguished Teaching Award • Brian Potoski, Outstanding Clinical Practice In Infectious Diseases Pharmacotherapy Award, Society of Infectious Diseases Pharmacists • Shilpa Sant, Biomedical Engineering Society, rising star/fellow • Susan J. Skledar, American Society Of Health-System Pharmacists, Inpatient Care Practitioners Distinguished Service Award

Grants

• Kim C. Coley, Pharmacist-led InterVention on Transitions of Seniors: PIVOTS, UPMC, American Society of Health-System Pharmacists • Donna Huryn, p97, Liedos Biomedical Research, Inc, NCI • Paul Johnston, Selective V4-GEF-H1 MIHA Growth Inhibition Screen, Chinese University of Hong Kong.

• Paul Johnston, Identifying Synergy between APE1 DNA Repair Inhibitors and Approved Melanoma Cancer Drugs, NIH • Paul Johnston, STAT Mediated TGF a/EGFR Signaling in Squamous Cell

48

ACADEMIC PHARMACY NOW 

Carcinomas of the Head & Neck, NIH • Paul Johnston, PI3K Pathway Mutations in Head and Neck Cancer, NIH • Thomas Nolin, Drug Metabolizing Enzyme and Transporter Function in Chronic Kidney Disease, NIH (Tom is co-PI with University of Colorado PI) • Samuel M. Poloyac, Operation Brain Trauma Therapy Extended Studies, Department of Defense • Janice Pringle, Clearfield-Jefferson Drug and Alcohol Commission SBIRT Project, Behavioral Health Alliance of Rural Pennsylvania • Janice Pringle, Implementation of Screening, Brief Intervention and Referral to Treatment within the Medical Community of Blair County, Blair Drug and Alcohol Partnership, Pennsylvania Commission on Crime and Delinquency • Janice Pringle, Overdose Prevention Coalition, Pennsylvania Commission on Crime and Delinquency • Shilpa Sant, Engineered Microenvironments to model effect of size in tumor progression, NIH • Wen Xie, The Hepatic Function of Cholesterol Sulfotransferase SULTB1b in Energy Metabolism, NIH • Wen Xie, A Novel Regulation of the Phase II Enzyme Estrogen Sulfotransferase, NIH • Xiang-Qun (Sean) Xie, NIDA Center of Excellence OF Computational Drug Abuse Research (CDAR), NIH

Promotions

• Neal J. Benedict, associate professor of pharmacy and therapeutics • Jan Beumer, tenure, associate professor, Department of Pharmaceutical Sciences

Retirements

• Regis R. Vollmer, professor of pharmaceutical sciences, named professor emeritus.

University of Saskatchewan Appointments/Elections

• Rhett Carbno, lecturer in pharmacy • Tracy Everitt, nutrition professional skills coordinator • Stephanie Mulhall, coordinator, assessment and evaluation • Tanya Nystrom, pharmacology

2014 Issue 3

• Courtney Quiring, lecturer in pharmacy • Bill Semchuk, Jennifer Bolt, pharmacology • Ellen Wasan, assistant professor of pharmacy • Kishor M. Wasan is the new dean of pharmacy and nutrition at the University of Saskatchewan.

Grants

• David Blackburn, co-investigator, and other researchers at UBC were awarded a $390,000 CIHR Partnerships for Health System Improvement grant.

• Ildiko Badea and colleagues were recently awarded a $200,000 research grant from the Sylvia Fedoruk Canadian Centre for Nuclear Innovation to develop and track the targeted delivery of drugs using nuclear imaging.

• Hector Carucho received a Saskatchewan Health Research Foundation Establishment Grant ($120,000) for his work on biomarkers of depression.

• Kishor M. Wasan and his UBC colleagues were awarded a $236,000 research grant from the Foundation Fighting Blindness of Canada to test a new compound against eye defects.

• Carol Henry and Gord Zello are working with Bert Vandenberg, Plant Sciences and colleagues at BRAC University in Bangladesh on a diet-based solution to iron deficiency. This work recently received $120,000 seed funding from Grand Challenges Canada.

Promotions

• Roy Dobson and Gord Zello were appointed acting assistant deans of Pharmacy, and Nutrition and Dietetics, respectively for the next six months.

University of Southern California Appointments/Elections

• Kermit Crawford has been appointed Executive in Residence and Senior Advisor to the Dean.

Awards

• Scott Evans was named Hospital CEO of the Year at the Los Angeles Business Journal’s Health Care Leadership Awards.

Grants

• Paul Beringer was awarded $192,377 from the Cystic Fibrosis Foundation for

faculty news “Targeting CF Infection and Inflammation with Aerosolized Theta-defensin.

• Tien Ng garnered a grant of $217,626 from Otsuka America Pharmaceuticals, Inc. to conduct the study “Aquaresis Utility for Hyponatremic Acute Heart Failure (AQUA-AHF).”

University of Wisconsin– Madison Appointments/Elections

• Steven M. Swanson, dean, School of Pharmacy

Virginia Commonwealth University Appointments/Elections

• Rachel Flurie has been named assistant professor, Department of Pharmacotherapy Outcomes and Science.

• Aaron May has been named assistant professor, Department of Medicinal Chemistry.

• Mary Jayne Kennedy was appointed to the editorial board of Obstetric and Pediatric Pharmacology and to the ASCPT Scientific Awards Selection Committee.

• Abigale Matulewicz has been named an assistant professor, Department of Pharmacotherapy and Outcomes Science and Foundations Lab. • Amy L. Pakyz earned her Ph.D. in health services organization and research from VCU School of Allied Health Professions.

• Ron Polk has been appointed professor emeritus, School of Pharmacy, and affiliate professor, Department of Internal Medicine.

• Patricia W. Slattum was appointed chairwoman of the ASCPT Mentor Task Force.

• Jeremy S. Stultz was appointed chairman-elect of the Pediatric Pharmacy Advocacy Group Research Committee.

Awards

• Gretchen Brophy was named a fellow of the Neurocritical Care Society.

• Joseph T. DiPiro received the American College of Clinical Pharmacy’s 2014 Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy.

• Dave L. Dixon received a Fellow of the National Lipid Association Award

and was appointed an at-large board member (three-year term) of the NLAs Southeast Lipid Association.

• Keith Ellis received the VCU School of Pharmacy 2014 Faculty Award for Excellence in Teaching.

• Richard A. Glennon was inducted into the American Chemical Society’s Division of Medicinal Chemistry Hall of Fame and named recipient of the ACS Division of Medicinal Chemistry’s Fifth Annual Philip S. Portoghese Medicinal Chemistry Lectureship.

• Jean-Venable “Kelly” Goode was named president-elect of the American Pharmacists Association and also received Virginia Pharmacists Associations 2014 Ed D. Spearbeck Virginia Pharmacist Service Award.

• Michael Hindle’s co-authored paper, Development and Comparison of New High Efficiency Dry Powder Inhalers for Carrier-Free Formulations, was selected as an editor’s pick by the Journal of Pharmaceutical Sciences.

• Cynthia K. Kirkwood received the College of Psychiatric and Neurologic Pharmacists Judith J. Saklad Memorial Award.

• Gary R. Matzke’s co-authored paper, Interactive Preventive Health Record to Enhance Delivery of Recommended Care: A Randomized Trial, won the 2014 Society of Teachers of Family Medicine Best Research Paper Award.

• Evan Sisson was named a fellow of the American Association of Diabetes Educators.

• Patricia W. Slattum will receive the American Society of Clinical Pharmacology and Therapeutics 2015 Henry Elliott Distinguished Service Award.

• Victor A. Yanchick received the Medical College of Virginia Foundations 2014 Robert Irby Award for Medical College of Virginia Campus Faculty Volunteer.

• VCU School of Pharmacy’s Pharmacist Collaborative Care and Outreach in the Community project (which includes 14 faculty members) was named by the Association of Public and Land-Grant Universities as a regional winner of the 2014 Engagement Scholarship/W.K. Kellogg Foundation Engagement Award and as a finalist for the C. Peter

Magrath University Community Engagement Award.

Grants

• Malgorzata Dukat, Biophore Pharma, $10,000, unrestricted for research.

• Edwin van den Oord and Karolina Aberg, National Institute of Mental Health, $3 million in collaboration with Duke University School of Medicine to study molecular marks left by adverse events in childhood.

• Ben Van Tassell, National Heart, Lung and Blood Institute, $1.2 million in collaboration with a VCU School of Medicine colleague, Interleukin-1 Blockade in Acute Myocardial Infarction and Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction.

• Karolina Aberg, National Institute of Mental Health/NIH/DHHS, $150,000, Mediators of Methylomic Profiles in 1,500 Schizophrenia Cases and Controls.

• Malgorzata Dukat and Douglas Sweet, VCU Presidential Research Quest Fund, $50,000, hOCTs as Promising Targets for Antidepressant Action: Early Structure-Activity Studies.

• MaryPeace McRae, VCU Center for Clinical and Translational Research Endowment Fund, $47,000, Functional Consequences of HIV and Methamphetamine Interactions at the Blood Brain Barrier.

• Susanna Wu-Pong, VCU Quest Innovation Fund, $50,000, VCU BEST (Broadening Experiences in Scientific Training) Program.

Promotions

• Yan Zhang, associate professor with tenure • Sharon Gatewood, associate professor, Department of Pharmacotherapy and Outcomes Science.

• Patricia Horning, assistant professor, Department of Pharmacotherapy and Outcomes Science.

• Glen Kellogg, professor, Department of Medicinal Chemistry.

• Patricia W. Slattum, professor, Department of Pharmacotherapy and Outcomes Science.

• Shijun Zhang, associate professor, Department of Medicinal Chemistry.

ACADEMIC PHARMACY NOW 

2014 Issue 3

49

faculty news Washington State University

Appointments/Elections

• Ayesha Ahmed, associate in research, Department of Pharmacotherapy • Salah-uddin Ahmed, associate professor, Pharmaceutical Sciences; • Nahid Akhtar, research associate, Pharmaceutical Sciences • Danial E. Baker has been appointed to a four-year term as consultant to the U.S. Food and Drug Administration Arthritis Advisory Committee.

• Ross J. Bindler, research associate, Department of Pharmacotherapy • Alyson Blum, research associate and obstetrics resident, Department of Pharmacotherapy • Dafeng Chu, postdoctoral research associate, Pharmaceutical Sciences • Travis Denton, clinical assistant professor, Pharmaceutical Sciences; • K. Michael Gibson, professor, Experimental and Systems Pharmacology, was appointed to the Allen I. White endowed professorship in the WSU College of Pharmacy; • Anne Kim, research associate, Department of Pharmacotherapy • Liza Koren-Selfridge, clinical assistant professor, Department of Pharmacotherapy • Linda G. MacLean has been elected to serve a three-year term on the board of trustees for the American Pharmacists Association beginning in March 2015.

• Sue Marsh was appointed to the American Physiological Society’s Women in Physiology Committee for a three-year term from January 1, 2015, through December 31, 2017.

• Mary Paine has been named associate editor of Clinical Pharmacology & Therapeutics, published by Nature.

• Tawndi Sargent, clinical assistant professor, Department of Pharmacotherapy; • Anil Singh, research associate, Pharmaceutical Sciences; • Sergei Tolmachev was appointed to a second three-year term as an adjunct professor at Laval University, Department of Chemistry in Quebec, Canada.

50

ACADEMIC PHARMACY NOW 

• Sadiq Umar, postdoctoral fellow, Pharmaceutical Sciences; • Kara Vogel, postdoctoral research associate, Experimental and Systems Pharmacology • Zhenjia Wang was elected to the editorial board of the Austin Journal of Analytical & Pharmaceutical Chemistry.

• Christy J. Watson, associate in research, Pharmaceutical Sciences

Grants

• K. Michael Gibson received an R21 grant from the National Institutes of Health Division of National Institute of Neurological Disorders and Stroke in the amount of $432,400 over two years for his research project titled, Therapeutics of mTOR Signaling in Succinic Semialdehyde Dehydrogenase Deficiency.

• Gary Meadows and Hui Zhang received $415,250 from the National Institute for Alcohol Abuse and Alcoholism for a research project, “Immunotherapy to mitigate the negative effects of alcohol on cancer progression.”

• Gregory Poon received a grant of $510,364 over three years from the National Science Foundation for the project, “Molecular basis of DNA specific and non-specific site recognition by ETS transcription factors.” He also received a grant of $431,958 over three years from the National Institutes of Health for the project, “Osmotic responsiveness of the master immune regulator PU.1.”

• John R. White Jr. received a grant from the American Beverage Association in the amount of $263,000 for his one-year research project, “Pharmacokinetic Analysis of Caffeine (160 mg) Administered Rapidly via Chilled Coffee, Chilled Energy Drink or Slowly via Hot Coffee or Chilled Coffee or Energy Drink.”

• Carol Wysham received a grant from Quintiles Inc. who represents the sponsor Boehringer Ingelheim Pharmaceuticals for “A multicenter, international, randomized, parallel group, doubleblind, placebo-controlled CArdiovascular safety & Renal Microvascular outcome study with LINAgliptin, 5 mg once daily in patients with type 2 diabetes mellitus at high vascular risk (CARMILNA).” The award is for $93,531 over five years.

2014 Issue 3

Retirements

• William E. Fassett, professor, Department of Pharmacotherapy

Wayne State University Appointments/Elections

• Kyle J. Burghardt, assistant professor of pharmacy practice • Vanessa E. Millisor, clinical assistant professor of pharmacy practice • Christine A. Rabinak, assistant professor of pharmacy practice

Grants

• Susan Laroque Davis, Cubist Pharmaceuticals $151,996, Patient Outcomes and the Burden of Illness with Lower Respiratory Infections • Arun Iyer, National Cancer Institute, NIH, $372,000, Targeted Platinates/siRNA Combination Therapy for Resistant Lung Cancer • Michael J. Rybak, National Institute of Allergy and Infectious Diseases, NIH, $380,000, Impact of Daptomycin Dose Exposure on Biofilm Enterococci Resistance • Zhenping Yi, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, $1,350,000, Human Skeletal Muscle Proteome and Phosphoproteome in Obesity and Type 2 Diabetes

Promotions

• Raymond Cha, clinical associate professor • Francine D. Salinitri, clinical associate professor

Retirements

• Henry Wormser, professor of pharmaceutical sciences

Western University of Health Sciences Grants

• Arezoo Campbell, studies ambient particulate matter neurotoxicity. British Petroleum/South Coast Air Quality Management District funded $577,590 over two years.

• Ying Huang, studies novel anticancer drug formulations. FULGENT Therapeutics funded $532,506 (multiple contracts).

• Fadi T. Khasawneh, studies platelet Gprotein coupled receptors. NIH funded $416,976 over three years.

faculty news • Peter Oelschlaeger, studies bicyclic beta-lactam antibiotic stability against beta-lactamases. NIH funded $144,540 over three years.

• Sunil Prabhu, studies nanotechnology-based regimens for pancreatic cancer chemoprevention. NIH funded $438,000 over three years.

• David Sanchez, studies immunity against AIDS-associated malignancies.

NIH funded $219,000 over two years.

Wilkes University Awards

• Scott Bolesta was accepted into American College of Clinical Pharmacy’s Focused Investigator Training Program.

Grants

• Judith Kristeller, Community Pharmacy Foundation, $93,500, Hospital and Community Pharmacist Collaboration to Improve the Transition of Care from Hospital to Home. She also received $40,000 from the Moses Taylor Foundation for the same project.

• Eric A. Wright is the principal investigator on a $600,000 research grant awarded to Geisinger Health System from the National Associations of Chain Drug Stores Foundation.

CLICK AND RECRUIT: AACP’s Online Career Center Take advantage of the best recruitment tool in the academic pharmacy community: the AACP Online Career Center.

Posting a job—and reaching a large pool of candidates— is easy and inexpensive. Just go to http://pharm.aacp. associationcareernetwork.com and click on Job Search or Employer Home to view instructions and fees.

For more information, contact Kyle R. Bagin at kbagin@aacp.org or 703-739-2330 ext. 1036.

Promotions

• Jennifer Malinowski, associate professor of pharmacy practice, was awarded tenure.

Emerging Institutions Keck Graduate Institute Appointments/Elections

• David R. Ha, assistant professor of clinical sciences • Connie Kang, assistant professor of clinical sciences • Robert L. Stein, professor of practice for pharmacy law and ethics • Rachita K. Sumbria, assistant professor of biopharmaceutical sciences • Ken S. Wong, associate professor of administrative sciences • Alexander Zambon, assistant professor of biopharmaceutical sciences

Post a Job

ACADEMIC PHARMACY NOW 

2014 Issue 3

51

American Association of Colleges of Pharmacy Discover · Learn · Care : Improve Health

1727 King Street · Alexandria, VA 22314 p: 703-739-2330 · f: 703-836-8982 · www.aacp.org For address change, please return mailing label with current school affiliation.

Register Online Now

2015 AACP Interim Meeting

February 7–10 / Hilton Austin / Austin, Texas Teams Leading Change Learn how successful teams are at the forefront of leading change in pharmacy education and practice.

Bring your team to Austin and return with effective strategies and practical tools.

www.aacp.org/interimmeeting15

Save the Date 2015 AACP Institute

May 18–20 / Hilton Atlanta Airport